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Abstract 
 
Purpose: The primary aim of this study was to evaluate the efficacy of brushing with the 
probiotic Lactobacillus reuteri on plaque accumulation and gingival inflammation. This 
study included 34 healthy adult subjects, ages 18-65, exhibiting gingivitis. Participants 
were asked to participate in a randomized, double-blind, placebo controlled study testing 
whether brushing with L. reuteri probiotic drops added to toothpaste reduced the clinical 
parameters of gingivitis more than brushing with a placebo drop added to toothpaste. 
Methods: Biological measurements of plaque accumulation were recorded using 
disclosing solution and an O’Leary Plaque Score (PS), and gingival inflammation was 
recorded using a modified Löe-Silness Gingival Index (GI). Each participant was 
randomly divided into one of two groups: group A or group B followed by baseline data 
collection of clinical parameters. Participants were assigned their study drops to add to 
their study toothpaste. 
Results: Analysis included both descriptive and inferential statistics. Inferential statistics 
employed Wilcoxon Signed Rank tests, due to the small sample size and inability to 
assume normal distribution of the study population. Statistical significance level was set 
at p < 0.05. Variables included median differences between the probiotic and placebo 
groups’ baseline and final data for both PS and GI. Comparisons were also made by age 
and gender, and to evaluate the difference between final PS for placebo versus probiotic 
and final GI for placebo versus probiotic. Statistically significant differences were 
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noticed between baseline and final data for GI of the placebo group as a whole (p = 
0.001), and females of the placebo group (p = 0.004). No statistical difference was noted 
in PS between baseline and final data for either group. 
Conclusion: Although results of this clinical study were unexpected, further research 
regarding the use of probiotics as a natural, healthy alternative therapy to antibiotics for 
the treatment and management of oral diseases should continue to be evaluated. Several 
research studies reviewed in the process of completing this thesis have shown probiotics 
have great possibilities in the oral cavity. Most researchers agree the type, application 
method, and quantity of probiotic needed to be effective at treating and managing oral 
diseases has yet to be determined. 
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Introduction/Literature Review 
Introduction to the Research Question 
Probiotics are defined by the Food and Agricultural Organization (FAO) of the 
World Health Organization (WHO) as “live microorganisms that, when administered in 
adequate amounts, confer a health benefit on the host” (Venugopalan, Shriner, & Wong- 
Beringer, 2010, p. 1661). Use of probiotics can be traced back in time to dates before 
microbes were even discovered. Pictures of Egyptian hieroglyphics depicting fermented 
milk products have been uncovered, and it is known Tibetan nomads used fermented yak 
milk to preserve their milk during long journeys (McFarland, 2015). Subcategories of 
probiotics include foods, food ingredients, and supplements containing live 
microorganisms (Venugopalan et al., 2010, p. 1661). Probiotics come in many forms, 
such as tablets or pills that are ingested, and often they are naturally occurring in common 
foods we eat daily. Sometimes they are added by food manufacturers to enhance the 
health claims of their products. Examples of probiotic foods and beverages include 
yogurt, Kefir, fermented milk products and cheese, buttermilk, miso, kimchi, sauerkraut, 
and many other foods and beverages. 
Since the early twentieth century, beneficial micro-organisms have been used to 
support immune function and prevent and manage health problems. These useful 
bacteria, named probiotics, derived from the Greek term meaning “for life,” have been 
proven effective in controlling chronic gastrointestinal diseases such as Crohn’s disease, 
ulcerative colitis, and other irritable bowel disorders (Anusha, Umar, Basheer & Baroudi, 
2015; Isolauri, 2001). In their systematic review on probiotics, Vuotto, Longo, and 
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Donelli, (2014), discuss research studies that demonstrate probiotics are effective in the 
treatment or prevention of acute viral gastroenteritis, pediatric post-antibiotic-associated 
diarrhea, certain pediatric allergic disorders, necrotizing enterocolitis in preterm infants, 
inflammatory bowel diseases, and post-surgical pouchitis (Vuotto et al., 2014). 
With the growing concern regarding overuse of antibiotics, and the emergence of 
multi-resistant strains of bacteria, scientists have looked back through history to review 
methods for fighting diseases. This retrospection brought to light the forgotten concept 
of using bacteria beneficial to health to combat infectious diseases (Meurman, 2005). 
Similarities between the types of microbiota living in the gastrointestinal tract and oral 
cavity of healthy people led investigators to consider whether the beneficial effects 
exhibited by probiotics in the gastrointestinal tract would show comparable results in the 
oral cavity (Pandey, Berwal, Solanki, & Malik, 2015). Current research on probiotics in 
the oral cavity utilizing several different types of microbes, and methods of application, 
have yielded mixed results (Gupta & Gupta, 2010). 
Theories for inconsistent study results have been attributed to variances in the 
mechanism of action of different probiotics. Known mechanisms of action include 
immune modulation, production of anti-microbial substances, competitive exclusion 
theory, hindrance of adhesion of pathogenic bacteria, and competition for nutrients 
(Teughels, Loozen, & Quirynen, 2011). However, most studies executed to date indicate 
a need for additional research to determine the efficacy of application methods employed, 
and mechanism of action of probiotics in the oral cavity. This study attempted to 
determine the efficacy of brushing with the probiotic L. reuteri, as an application method 
by evaluating the results on the common oral disease, gingivitis. 
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Statement of Problem 
 
Using probiotics for the treatment of gastrointestinal ailments is well documented, 
demonstrating their health promoting potential (Haukioja, 2010), and good benefit-to-risk 
ratio (Krasse et al. 2005). Probiotics have been proven to be an effective approach to 
reducing symptoms related to gastrointestinal diseases (Isolauri, 2001). Research studies 
seeking to examine the effects of probiotics on gastrointestinal diseases have evaluated 
many types of bacteria. Although several different probiotic strains have been found to 
be beneficial, probiotics with the ability to adhere to mucus and epithelial cells have been 
proposed as one of the most important selection criteria for potential probiotic strains 
(Vuotto et al., 2014). 
In the oral cavity, beneficial and pathogenic bacteria maintain a delicate balance. 
The accumulation of anaerobic gram-negative bacteria within the dental biofilm 
predisposes otherwise healthy individuals to periodontal diseases by transforming dental 
plaque into a difficult to treat pathogenic biofilm (Vuotto et al., 2014). Therefore, “oral 
cavities have been suggested as a relevant target for probiotic applications, through the 
use of non-pathogenic, bacteriocin-producing Lactobacilli and Bifidobacteria to restore 
the microbial balance and to counteract pathogenic bacteria” (Vuotto et al., 2014, p. 189). 
L. reuteri is often chosen for studies due to its historically recorded safety, and ability to 
produce two bacteriocin, reuterin and reutericyclin (Haukioja, 2010; Raff & Hunt, 2012). 
Bacteriocin are antibacterial substances produced by certain bacteria, that kill or 
inhibit the growth of closely related bacteria species or other strains of the same bacteria 
(The American Heritage® Medical Dictionary, 2007). Reuterin and reutericyclin have 
the ability to inhibit the growth of several different pathogens by adhering to host tissues, 
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resulting in competition for pathogenic bacteria, and reducing the secretion of 
proinflammatory cytokines (Gupta, 2011). Cytokines are proteins secreted by cells that 
effect communication and interaction between cells. Pro-inflammatory cytokins are 
released as part of the bodies immune system. They are produced by cells during cell 
injury, infection, invasion, and inflammation, and have been shown to be the cause of 
injury related pain (Zhang & An, 2007). Given the proven benefit of probiotics, and 
similarities in microbiota between the gastrointestinal tract and the oral cavity, probiotics 
may be effective at reducing oral diseases. 
Previous application methods to introduce probiotics into the mouth have yielded 
inconsistent results (Hallstrom et al., 2013; Harini & Anegundi, 2010; Iniesta et al., 2012; 
Karuppaiah et al., 2013). Various methods of application have been studied, however, 
limited studies exist that have evaluated brushing with probiotics as a means of direct 
application to the oral tissues (Hallstrom et al., 2013; Harini et al., 2010; Iniesta et al., 
2012; Karuppaiah et al., 2013). The efficacy of brushing has been determined as an 
effective treatment for reducing gingivitis (Lang et al., 1973; Slot, Wiggelinkhuizen, 
Rosema, & Van der Weijden, 2012; Sowinski et al., 2008). Based on this information, it 
appears there is a gap in the research regarding the efficacy of brushing with probiotics, 
as this practice has yet to be thoroughly evaluated. In order to address this deficiency, 
this study sought to answer the following question: 
• Will brushing with toothpaste and L. reuteri probiotic drops reduce clinical 
parameters of gingivitis in healthy adults in comparison to brushing with 
toothpaste and placebo drops? 
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Overview of Research 
 
Gingivitis is a common chronic disease affecting the crevice (sulcus) surrounding 
the teeth of humans and animals, and limited to the gingiva. It is caused by an 
accumulation of bacteria in the form of dental plaque, also known as bacterial biofilm, 
around these crevices, resulting in an inflammatory response from the body’s immune 
system (Krasse, et al. 2005) (Fig. 1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Gingivitis 
 
Clinical assessments often utilized to measure gingivitis include PS, GI, periodontal 
probing depths (PD), and bleeding on probing (BOP) (Amižić et al., 2016; Hallstrom et 
al., 2013; Harini et al., 2010; Iniesta et al., 2012; Karuppaiah et al., 2013; Krasse et., al. 
2005; Slawik et al., 2011; Twetman et al., 2009). Initial treatment for gingivitis usually 
incorporates brushing instruction to improve a patient’s oral hygiene (Krasse et. al., 
2005). However, clinical studies show gingivitis is a recurrent infection, despite earlier 
successful treatment (Krasse et al., 2005). In a study by Lang et al. (1973), they discuss 
information gained from previous research performed by Löe, Theilade & Jensen (1964) 
entitled Experimental Gingivitis in Man, noting “It has been shown that if oral hygiene 
procedures are suspended, localized gingivitis develops in only 4-11 days and generalized 
EFFICACY OF BRUSHING WITH PROBIOTICS 6  
 
 
gingivitis within 2-3 weeks. On the other hand, resumption of oral hygiene procedures 
has resulted in a dramatic improvement in gingival health” (Lang et al., 1973, p. 396). 
Due to the documented beneficial effects of probiotics on inflammatory  
gastrointestinal diseases, and the similarities of the oral and gastrointestinal microbiota, 
scientist are searching for ways to test whether probiotics would be beneficial in reducing 
clinical and systemic parameters associated with oral inflammatory diseases. Research 
designs evaluating the use of probiotics in the oral cavity vary greatly. Methodology for 
these studies has included systemic, topical, and site specific evaluation of probiotics on 
the oral environment (Amižić et al., 2016; Hallstrom et al., 2013; Harini et al., 2010; 
Iniesta et al., 2012; Karuppaiah et al., 2013; Krasse et., al. 2005, Shimauchi, 2008;  
Slawik et al., 2011, Teughels et al., 2011; Teughels et al., 2013; Twetman et al., 2009). 
Systemic Introduction of Probiotics 
Systemic introduction through ingestion of probiotics is one of the ways probiotics 
have been tested for their therapeutic benefit to oral health. This method involves the 
consumption of probiotics through food and tablets. Evaluative methods of this design 
have included saliva samples, subgingival plaque samples, PS, PD, BOP, and GI (Iniesta 
et al., 2012; Karuppaiah et al., 2013; Slawik et al., 2011). These research designs showed 
some promising results, however, constraints exist with this method, such as limited 
contact time to oral tissues, and degradation of probiotics due to stomach acid (Lawande, 
2012). 
Slawik et al. (2011), determined the effects of a probiotic milk drink on clinical 
inflammatory parameters of the oral gingiva. The bacteria contained in the milk drink 
was Lactobacillus casei Shirota strains with concentrations of 1x10
8 
colony forming 
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bacterial units (CFU) per ml, and each milk drink was 65 ml. This 28-day study included 
healthy adults (N = 28) age 20 to 33 (16 females, 12 males), non-smokers, with no  
clinical signs of gingival inflammation, probing pocket depths 3mm or less, attachment 
loss 2 mm or less, and a GI of zero at baseline. A test group (n = 11), and a control group 
(n = 17), were utilized for comparison. Evaluation methods of PS, GI, gingival crevicular 
fluid (GCF), and bleeding on probing (BOP) were collected. The study began with a 14- 
day non-brushing period to induce gingivitis, and evaluated six teeth on the right side of 
the maxilla. Researchers concluded the data based on a controlled experimental setting 
indicate an anti-inflammatory effect of the tested probiotic milk drink. The inflammatory 
parameters of BOP and GCF were significantly lower for the test group compared to the 
control group (p = 0.005). There was an increase in plaque accumulation indicated by an 
increased PS, which was attributed to the high amount of carbohydrate in the probiotic 
milk drink (Slawik et al., 2011). 
In contrast to Slawik et al. (2011), Karuppaiah et al. (2013) demonstrated reduced 
levels of plaque when using probiotics compared to a control group. The aim of this 
study was to evaluate the efficacy of probiotics in plaque reduction among school 
children. This study consisted of healthy children age 14 to 17 (N = 216), and 
participants were divided into two groups. For 30 days, the test group (group A, n = 108) 
included curd in their diet, and the control group (group B, n = 108) excluded curd from 
their diet. Curd is derived from the fermentation of milk, and contains probiotics similar 
to yogurt (India Parenting, 2017). At the conclusion of this study, Karuppaiah et al., 
(2013) found both groups had a decrease in GI from the baseline, this was attributed to 
the prophylaxis prior to the study. Prophylaxis is defined by the American Dental 
EFFICACY OF BRUSHING WITH PROBIOTICS 8  
 
 
Association (ADA) as the professional removal of plaque, calculus and stains from the 
tooth structures in the permanent and transitional dentition. It is intended to control local 
irritational factors (ADA, 2017). This study did find a significant difference in PS (p < 
0.001) in regard to the curd group (group A), showing an overall decrease in plaque 
accumulation as compared to the control group. Limitations for this study include the 
short period of the study trial. Examiners concluded the reduction in PS and GI of the 
probiotic group suggests probiotics may have reduced gingival disease, however further 
long term studies are needed to confirm this implied benefit (Karuppaiah et al., 2013). 
Iniesta et al. (2012) found no significant difference in PS and GI with people who 
consumed tablets containing L. reuteri (Iniesta et al., 2012). This study (N = 40) utilized 
a double-blind, prospective, placebo-controlled, crossover randomized clinical trial with 
two test periods of four weeks, and an intermediate washout period of four weeks. 
Subjects in this study consumed one tablet per day for 28 days of either the placebo 
(control group, n = 20), or L. reuteri (test group, n = 20) containing tablets with 2 x10
8
 
 
CFU per tablet. Data was taken at baseline, week four, and week eight to evaluate saliva, 
subgingival plaque, PS and GI. Collection of microbiological samples to evaluate 
colonization patterns of L. reuteri were collected every two weeks for fourteen weeks, 
and analyzed using standard qualitative polymerase chain reaction (PCR) analyses. 
Results of the research showed colonization of the saliva and subgingival habitat of some 
gingivitis patients was possible to achieve by consuming L. reuteri containing tablets. A 
discussion on the lack of clinical significance stated possible reasons for this could have 
been the short duration of the study, or the sample population, being primarily female 
dental students with above average oral hygiene, making it difficult to determine any 
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significant change (Iniesta et. al., 2012). 
Vicario et al. (2013) used a double-blind placebo-controlled, randomized clinical 
trial over a 30-day test period to evaluate the clinical effects of L. reuteri Prodentis® in 
the treatment of initial to moderate periodontitis. Clinical parameters assessed PS, PD, 
BOP, and data was gathered at the initial onset of the study and the end of the study. 
Participants included healthy adults (N = 19), divided into one of two groups, test group 
(n = 10) or placebo group (n = 9). The test group ingested one tablet daily for 30 days of 
two different strains of L. reuteri Prodentis® known as Gum PerioBalance® (Sunstar, 
Switzerland) containing 2 x 10
8 
CFU per tablet. The placebo group received a tablet of 
inert ingredients containing no L. reuteri Prodentis®. Results of this study show 
periodontal parameters of PS, PD, and BOP achieved clinically significant reductions for 
the test group after the 30-day trial was complete (p < 0.05). The placebo groups did not 
show any significant changes for any of the parameters evaluated. In their conclusion, 
investigators of this research stated the reduction in all clinical parameters measured in 
this study demonstrated L. reuteri Prodentis® may be useful in the treatment of initial to 
moderate periodontitis (Vicario et al., 2013). 
 
Shimauchi et al. (2008) found probiotics may be useful in improving periodontal 
health with individuals in high risk groups for periodontal disease. This study (N = 67) 
did not exclude smokers, and utilized a double-blind, randomized, placebo-controlled 
design over eight weeks. The probiotic used for this study was Lactobacillus salivarius 
WB-21, and the test group (n = 34) consumed three tablets per day containing 
Lactobacillus salivarius WB21 (2.01 x 10
9 
CFU/day) and xylitol (840 mg/day). The 
control group (n = 33) received tablets with no probiotic, and xylitol only (840 mg/day) 
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and were directed to use tablets three times per day for eight weeks. Clinical parameters 
of BOP, PD, PS, GI, and salivary samples were collected to evaluate probiotic levels in 
plaque and saliva. Data collection was performed at baseline, week four and week eight. 
Results showed clinical parameters for both the test and placebo groups were improved 
after the eight-week intervention. This anomaly was attributed to attention bias 
(Hawthorn effect). Results did show participants who were smokers had a statistically 
significant improvement in PS and PD when compared to baseline (p < 0.05) at eight 
weeks, and salivary levels of lactoferrin were significantly reduced in this group 
(Shimauchi et al., 2008). 
Mayanagi et al. (2009) also used Lactobacillus salivarius WB-21 containing 
tablets in a research study to evaluate the effects on five different oral microbes: 
Aggregatibacter actinomycetemcomitans, Provotella intermedia, Porphyromonas 
gingivalis, Treponema denticola, and Tanerella forsythia. This study divided participants 
(N = 66) into two groups. The test group (n = 34) received tablets containing 2 x 10
9 
CFU per day of L. salivarius WB-21 and xylitol, and were directed to ingest these tablets 
three times per day for eight weeks. The control group (n = 32) received tablets with no 
probiotic, but they did contain xylitol, and were directed to use tablets three times per day 
for eight weeks. Data collection intervals were at baseline, week four, and week eight, 
and supragingival and subgingival samples were collected. Results showed a suppressive 
effect on numerical sums of the counts of these five bacteria in subgingival plaque 
leading the researchers to believe oral administration of L. salivarius WB-21 could be 
beneficial in periodontal treatment (Mayanagi et al., 2009). 
Montero et al. (2017) conducted a study using a combination of three different 
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types of probiotic bacteria. The aim of this study was to evaluate the effects of probiotics 
for treatment of gingivitis, and also the effect on subgingival microbiota. This six-week 
study included participants (N = 59) broken into two groups; test group and control or 
placebo group. The test subjects (n = 29) were instructed to ingest two tablets per day 
containing the probiotics Lactobacillus plantarum, Lactobacillus brevis, and Pediococcus 
acidilactici. The control group (n = 30) received the same tablet with no probiotic 
bacteria added. Clinical parameters assessed were GI, PS and an angulated bleeding 
score, performed by using a periodontal probe held at a 60-degree angle to the 
longitudinal axis of the tooth. Contact was made with the sulcular gingiva, gently 
pushing the tissue away from the tooth. Subgingival assessments were made by taking 
one sample from each quadrant from the area of highest gingival inflammation. Samples 
were collected with sterile paper points. Quantitative PCR was utilized to determine the 
DNA of each sample. Results showed a significant decrease in the amount of T.  
forsythia bacteria present in the test group (p < 0.008), but no statistically significant 
difference was shown for any clinical parameter between treatment groups. Conclusions 
stated use of a probiotic containing Lactobacillus plantarum, Lactobacillus brevis, and 
Pediococcus acidilactici induced a significant impact in the subgingival microbiota of 
users (Montero et al., 2017). 
Topical Introduction of Probiotics 
 
Another method of introducing probiotics into the oral environment is through 
topical application. Studies employing this method utilize rinses, gum, lozenges, and 
toothpaste containing probiotics and evaluate clinical parameters of PD, PS, GI, and BOP 
(Amižić et al., 2016; Hallstrom et al., 2013; Harini et al., 2010; Twetman et al., 2009; 
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Slawik et al., 2011). The principle aim of these research studies was to assess the 
efficacy of probiotics for the potential treatment of the oral diseases known as gingivitis 
and periodontitis, however studies exist that evaluate probiotics on other oral conditions 
such as caries (tooth decay), halitosis (bad breath), and Candida infections (yeast 
infections). 
Topical studies using mouthrinses. Harini et al. (2010) compared a probiotic 
oral rinse with a chlorhexidine gluconate rinse. Chlorhexidine mouthrinse has long been 
considered one of the most effective gingivitis reducing therapies available. In a 
systematic review by James et al. (2017), 51 research articles regarding chlorhexidine use 
and its effectiveness at reducing gingival inflammation and plaque were analyzed. 
Conclusions noted by the investigators of this review stated there is high-quality evidence 
showing chlorhexidine mouthrinse reduces PS, and in mild cases of gingival 
inflammation, GI has also been reduced. Conversely, their research showed insufficient 
evidence to determine whether chlorhexidine rinse has resulted in a reduction of GI in 
moderate to severe cases of gingivitis (James et al., 2017). The aim of this study by 
Harini et al. (2010) was to evaluate the efficacy of probiotic and chlorhexidine mouth 
rinses in the reduction of plaque and gingival inflammation in children. This study 
included healthy children (N = 45) age six to eight years of age. The trial was 14 days 
and utilized a double-blind parallel group study where subjects were randomly divided 
into one of three groups (n = 15): 
Group A: Control Group (mint water) 
Group B: Probiotic Group 
Group C: Chlorhexidine Group 
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Each group was instructed to rinse once daily for 60 seconds using 15 ml of the assigned 
solution, approximately 30 minutes after brushing, then expectorate residual rinse. Final 
results showed the probiotic group and the chlorhexidine group had less plaque 
accumulations compared to the control group, however, there were no significant 
differences in plaque accumulation between the probiotic and chlorhexidine groups. GI 
was also significantly different for the probiotic and chlorhexidine groups compared to 
the control group (p < 0.001). The probiotic group’s GI was significantly reduced when 
compared to the chlorhexidine group (p = 0.009), (mean = 0.2300 and 0.6805, 
respectively). The results of this study suggest an anti-inflammatory benefit of probiotics 
similar to the systemic application studied by Slawik et al., (2011) (Harini et al., 2010; 
Slawik et al., 2011). 
Yousuf et al. (2017) studied the effects of freeze dried powdered probiotics on 
gingival status and plaque inhibition in school children (N = 33). In this study, freeze 
dried probiotics containing Lactobacillus acidophilus, Bifidobacterium 
longum, Bifidobacterium bifidum and Bifidobacterium lactis (Prowel, Alkem 
Laboratories), lactic acid bacillus only (Sporolac, Sangyo), and a placebo powder calcium 
carbonate 250 g (Calcium Sandoz, Novartis) were assigned to two test groups and a 
placebo group. Each group (n = 11) included school children ages 12 to 15, who were 
instructed to mix the powder with 30 ml of water and swish once daily for three minutes, 
then expectorate the mouth rinse. The study period was three weeks, and clinical 
parameters of PS and GI were evaluated at baseline, day seven, day fourteen, and day 
twenty-one. Results indicated both probiotic groups had a statistically significant 
reduction (p < 0.05) in gingival status and plaque, while the placebo group showed no 
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significant difference in either clinical parameter. Investigators surmise the use of 
probiotic mouth rinses improves the oral health in children by significantly reducing the 
plaque accumulation and gingival inflammation (Yousuf et al., 2017). 
Nadkemy et al. (2015) conducted a study to assess and compare the plaque 
reducing benefit and anti-inflammatory potential between mouthrinses containing either a 
probiotic, 0.2% chlorhexidine, or saline. The probiotics of choice for this study consist of 
Lactobacillus acidophilus, Lactobacillus rhamnosus, Lactobacillus sporogenes, 
Bifidobacterium longum, and Saccharomyces boulardii. Methodology was a randomized 
parallel group of subjects (N = 45) over four weeks. Group A (n = 15) used the probiotic 
mouthrinse, group B (n = 15) were given a 0.2% chlorhexidine rinse, and group C (n = 
15) was the control group, and rinsed with normal saline. Pre-study oral prophylaxis was 
performed on all subjects, and oral hygiene instructions on brushing and flossing were 
given to all. Participants were instructed to rinse with 10 ml of their rinse, undiluted, for 
one minute twice daily 30 minutes after brushing, and expectorate. Clinical parameters  
of PS and GI were evaluated at baseline, week two and week four of the study. Results  
of this study indicate from baseline to week 4, the difference in PS between the probiotic 
and saline groups was clinically significant, as was the difference between the control and 
chlorhexidine groups (significance not noted as a p-value; mean values of PS for 
probiotics was 0.36 ± 0.14, control 1.1 ± 0.22, and chlorhexidine 0.21 ± 0.15). Similar 
findings were noted for GI, with both probiotic and chlorhexidine versus control showing 
clinical significance (significance not noted as a p-value; mean GI scores were 0.45 ± 
1.174 for probiotic, 1.03 ± 0.142 for control, and 0.40 ± 0.124 for chlorhexidine). 
Conclusions from this research state probiotics could be useful in improving and 
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maintaining periodontal health of individuals at risk for periodontitis. Although 
chlorhexidine and probiotic rinse seemed equally effective, probiotic may be a better 
alternative for periodontal management, because there are no known or proven toxicities 
to use, antibiotic resistance is not a concern with use, and they are a natural, biologically 
friendly substance (Nadkemy, 2015). 
Noordin and Kamin (2007) conducted a placebo-controlled, double-blind, 
crossover study consisting of two 14-day test periods to evaluate plaque and gingivitis in 
young adults. Participants (N = 32) were divided into two groups; group A and group B. 
At the onset of the first phase of this study, group A (n = 16) was given an active 
mouthrinse containing the bacteriocin nisin, extracted from Lactobacillus lactis, and 
group B (n = 16) received a placebo mouthrinse with no probiotic or bacteriocin. Each 
group was instructed to use their mouthrinse twice daily for 60 seconds, approximately  
30 minutes after brushing, and expectorate mouthrinse after rinsing. Measurements of PS 
and GI were taken at baseline, and at the end of 14 days, conclusion of phase one of the 
study. A washout period of four weeks was initiated after phase one, and when 
completed, phase two of the study commenced. Phase two involved having each  
previous group use the alternate therapeutic and placebo mouthrinse for 14 days. Data 
collection followed the same interval as phase one, with data collected at baseline and  
day 14, end of the study. Results of this study demonstrated a clinically significant 
reduction in gingival inflammation (GI) in the probiotic group when compared to the 
placebo (p < 0.001), as well as a clinically significant increase in plaque accumulation 
(PS) in the control group when compared to the probiotic group (p < 0.001). This 
difference in PS and GI led researchers to deduce probiotic mouthrinse is effective at 
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reducing plaque accumulation and gingival inflammation compared to a placebo 
mouthrinse. Therefore, a probiotic therapeutic mouthrinse may be an effective adjunct to 
regular oral hygiene for treating clinical parameters of gingivitis (Noordin et al., 2007). 
A study by Shah (2014) compared mouthrinses containing either probiotics, 
chlorhexidine, or fluoride. This 28-day study included children age six to ten years old 
(N = 40), divided into four groups (n = 10): 
Group A: Probiotic Group (probiotic not identified in the study) 
Group B: Chlorhexidine Group 
Group C: Fluoride Group (concentration of fluoride not identified in the study) 
Group D: Control Group 
Participants were instructed to rinse twice daily with 15 ml of their assigned rinse for 60 
seconds after brushing teeth. Rinse was then expectorated, and subjects were advised not 
to eat, drink or rinse their mouth for 30 minutes. Data was collected for PS and GI at 
baseline and day 28, conclusion of the study. Results showed a statistically significant 
difference in PS for all three therapeutic rinse groups when compared with the control 
group, with similar findings for all three groups compared (p < 0.001). No notable 
difference for GI was determined between the probiotic, chlorhexidine and fluoride group 
when these three groups were compared to each other, however, there was a significant 
decrease in GI between the control group and these three therapeutic groups (p < 0.001). 
These results led investigators to determine probiotic mouthrinse is effective at reducing 
plaque accumulation and gingival inflammation in children, and given the concern with 
side-effects associated with available therapeutic mouthrinses, probiotic mouthrinse  
could be a good alternative antiplaque agent (Shah, 2014). 
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Topical Studies Using Gum. Krasse et al. (2005) was one of the first research 
studies to investigate the use of probiotics related to gingivitis, and set the stage for future 
research in this domain. Methodology of this two-week study was a double-blind  
placebo controlled prospective randomized study, (N = 59) with moderate to severe 
gingivitis. Participants of this study were randomly divided into three groups and 
received one of two different L. reuteri chewing gums, or placebo chewing gum. Group 
one (n = 20) (LR-1) and group two (n = 20) (LR-2) received one of two different L. 
reuteri formulations, both of human origin, containing 1 x 10
8 
colony forming units 
 
(CFU) of live bacteria. Group 3 (n = 39) received a placebo. All participants of this 
study received a professional teeth cleaning and instruction on brushing and flossing 
technique prior to beginning the study. Participants were instructed to chew one piece of 
their study gum each morning and evening after brushing and flossing the teeth. Each 
participant used a total of 28 study gums during the 14-day clinical trial. Results showed 
a clinically significant difference PS for the L. reuteri groups LR-1 (p < 0.05) and LR-2 
(P < 0.01) when compared to the placebo group. This led investigators to conclude L. 
reuteri was effective at reducing both gingivitis and plaque in patients with moderate to 
severe gingivitis (Krasse et al., 2005). 
Twetman et al. (2009) conducted a two-week study using chewing gum 
containing two strains of L. reuteri, 1 x 10
8 
CFU per gum, in order to investigate the 
effects on gingival inflammation and specific inflammatory mediators in gingival 
crevicular fluid (GCF). This study was a randomized, double-blind, parallel, placebo 
controlled study using healthy adults (N = 42) with moderate levels of gingival 
inflammation. Three groups were included in the study, group A/P was given one active 
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and one placebo gum daily, group A/A received two active gums, and group P/P received 
two placebo gums per day. Participants were instructed to chew two study gums per day 
for 10 minutes each time. Results showed in all groups BOP and GCF had decreased 
during the chewing period, but results were only statistically significant (p = 0.05) for the 
A/P and A/A groups. The levels of TNF-alpha and IL-8 decreased significantly (p = 
0.05) in group A/A, but significant decreases on other inflammatory mediators were not 
observed. Research concluded the reduction of pro-inflammatory cytokines in GCF may 
prove the principle for a probiotic approach to reducing inflammation in the oral cavity 
(Twetman et al., 2009). 
Sinkiewicz et al. (2013) conducted a randomized double-blind placebo controlled 
trial (N = 23) to investigate the effects of L. reuteri on saliva after supplementation, and 
the probiotic effects of L. reuteri on PS and supragingival and subgingival microbiota. 
Participants were divided into two groups; test group (n = 11) and placebo group (n = 
12). The test group was given chewing gum developed by BioGaia AB, Sweden, 
containing L. reuteri 2 x 10
8 
CFU per gum. The placebo group received chewing gum 
 
being identical in size, shape, and taste, containing inert ingredients and no L. reuteri. 
Participants were instructed to chew two study gums per day for a minimum of 10 
minutes each for 12-weeks. Data gathered at baseline (visit 1), week 12 (visit 2), and 
week 16 (follow-up). Results of this study show no significant difference in PS for the 
test group when comparing visit one and visit two data. The control group, however, had 
a statistically significant increase in PS from visit one to visit two (p = 0.0023). From 
this information, the investigators of this study suggest L. reuteri may inhibit plaque 
accumulation, as shown by the previous research of Krasse et al. (2005) (Krasse et al., 
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2005; Sinkiewicz et al., 2013). 
 
Topical Studies Using Lozenges. Research by Hallstrom et al. (2013) used 
probiotic lozenges containing L. reuteri to test the effect on the inflammatory response 
and composition of supragingival plaque in healthy adult females (N = 18).  This three- 
week study utilized a double-blind, randomized, placebo-controlled, cross-over design. 
The experimentation site chosen was the buccal surface of first molars, and during the  
test period, a mouth-guard was worn during brushing to cover the teeth from the first 
premolar to the second molar to prevent accidental cleaning. Lozenges containing the 
probiotic or a placebo were taken twice daily, and data was collected for PS, GI, BOP  
and GCF (Hallstrom et al., 2013). The study concluded daily intake of probiotic lozenges 
did not significantly affect plaque accumulation or inflammatory mediators during 
experimental gingivitis. One limitation to consider is the short duration of time this study 
utilized (Hallstrom et al., 2013). 
Toiviainen et al. (2015) used lozenges containing Lactobacillus rhamnosus GG 
(LGG) and Bifidobacterium animalis subsp. lactis BB-12 (BB-12) to evaluate levels of 
salivary mutans streptococci (MS) and gingival inflammation in young adults (N = 60) in 
a randomized, controlled, double-blind trail. This four-week study included a test group 
(n = 29) and a control group (n = 31), and utilized a run-in procedure where subjects were 
instructed to use one chewing gum containing 42% xylitol, 18% sorbitol, and 5% maltitol 
four times per day for two weeks prior to the beginning of the study. After the run-in 
period was completed, subjects were broken into one of two groups; control/placebo, and 
test groups. The test group used lozenges containing 50% xylitol, 46% sorbitol, and 
probiotics LGG and BB-12 at levels of 2 x 10
9 
cells of each type of probiotic. The 
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control group received lozenges containing no probiotics, but the same polyol 
composition as the test lozenges. A Silness-Löe (1964) PS and Löe-Silness (1963) GI 
were utilized to evaluate plaque levels and gingival inflammation. Salivary samples and 
supragingival plaque samples were collected from 15 randomly chosen subjects per 
group, and cultured for microbe analysis. Results of this study show mean PS and GI 
values for the probiotic group significantly decreased (p = 0.016 for PS and p = 0.012 for 
GI), whereas no change was observed for the control group. Statistically significant 
changes in microbial composition were not demonstrated for either group. This 
information led investigators to surmise immune modulation could be a possible 
explanation for the improved PS and GI of the probiotic group. Therefore, taking 
probiotics topically may improve the periodontal health of healthy individuals 
(Toiviainen et al., 2015). 
In a randomized, placebo-controlled, double-blind, split-mouth designed study, 
Vivekananda et al. (2010) used lozenges containing L. reuteri 1 x 10
8 
CFU (Prodentis®, 
BioGaia AB, Stockholm, Sweden) or a placebo lozenge, to evaluate the effects of L. 
reuteri alone, and in combination with scaling and root planning. Healthy adults (N = 30) 
with chronic periodontitis were included in this split-mouth study design. Each 
participant receiving scaling and root planning (SRP) on two quadrants, and the other two 
quadrants were left untreated. At day 21 after SRP, participants were divided into two 
groups (n = 15) and given lozenges, identical in appearance, except one group received 
lozenges with probiotics added, and the other group received placebo lozenges. 
Participants were instructed to use lozenges twice daily from day 21 to day 42 of the 
study. Data for clinical parameters of PS, GI, PD, BOP, and clinical attachment level 
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(CAL), and microbial parameters for Aggregibacter actinomycetemcomitans (Aa), 
Porphyromonas gingivalis (Pg), and Provotella intermedia (Pi) were collected at baseline, 
day 21, and day 42 of the study. Results of this study show both SRP plus probiotics and 
probiotics alone had the highest reduction of the three microbes assessed (p < 0.01, and p 
< 0.01 respectively). SRP plus placebo did not significantly reduce the evaluated 
pathogens. Clinical parameters of PS, GI, BOP exhibited clinically significant 
improvement for all treatment modalities. CAL and PD were most improved in the SRP 
plus probiotic group (p < 0.001, and p < 0.001 respectively). Based on the results, these 
researchers concluded this study confirms the plaque inhibition, anti-inflammatory, and 
antimicrobial effectiveness of L. reuteri containing lozenges (Prodentis®, BioGaia AB, 
Stockholm, Sweden), and recommended the addition of this therapeutic agent along with 
mechanical debridement, and during maintenance phases of periodontal treatment 
(Vivekananda et al., 2010). The lozenges tested during this study were provided by the 
company who developed them, BioGaia, AB, Stockholm, Sweden, and the researchers 
also received a publication grant from this company. Although the researchers in this 
study claim there is no conflict of interest involved with this study, this could be a 
limitation (Vivekananda et al., 2010). 
In a study by Ince et al. (2015) lozenges containing L. reuteri 1 x 10
8 
CFU 
 
(Prodentis®, BioGaia, Lund, Sweden) were used during initial periodontal therapy on 
patients with chronic periodontitis to evaluate the effects on clinical and biochemical 
parameters. This study was a randomized, double-blind, placebo-controlled, comparative 
study (N = 30). All participants were divided into two groups (n = 15) and received SRP 
and either lozenges containing the probiotic L. reuteri, or a placebo. Participants were 
EFFICACY OF BRUSHING WITH PROBIOTICS 22  
 
 
given their assigned lozenges at the beginning of initial SRP therapy, and instructed to 
take them twice daily for three weeks. Clinical parameters of PS, GI, BOP, and PD were 
assessed, along with biochemical parameters of gingival crevicular fluid (GCF), and pro- 
inflammatory and anti-inflammatory cytokines MMP-8 and TIMP-1 levels. Data was 
collected at baseline, day 21, day 90, day 180, and day 360. Results of this study  
revealed statistically significant differences in PS, GI, BOP and PD for the test group 
when compared to control (p < 0.05) for all clinical parameters measured, and across all 
data collection intervals. Biochemical parameters showed a clinically significant  
decrease in GCF MMP-8 and an increase in TIMP-1 levels for the test group at 180 days 
(p < 0.05). Researchers concluded L. reuteri containing lozenges may be a useful adjunct 
in the treatment of chronic periodontitis, and decreased MMP-8 and increased TIMP-1 at 
day 180 (p < 0.05) may demonstrate the anti-inflammatory benefit of this topical 
treatment. One limitation to consider in this study is the lozenges tested were provided  
by the company who developed them, BioGaia, AB, Lund, Sweden, although the 
researchers in this study claim there is no conflict of interest involved with this study, as 
the company was not involved in data management (Ince et al., 2015). 
In a very similar study conducted by Tekce et al. (2015), L. reuteri 1 x 10
8 
CFU 
 
(Prodentis®, BioGaia, Lund, Sweden) containing lozenges were also used during initial 
periodontal therapy to evaluate L. reuteri as an adjunctive therapy for the treatment of 
chronic periodontitis, and to detect levels of L. reuteri colonization in periodontal 
pockets. This study was a randomized, parallel, placebo-controlled, double-blind clinical 
trial lasting 360 days. Patients with chronic periodontitis (N = 40) participated in this 
study evaluating clinical parameters of PS, GI, BOP, and PD. Both the placebo (n = 20) 
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and probiotic group (n = 20) were given lozenges at the beginning of initial therapy, and 
instructed to take assigned lozenges twice daily for three weeks. Microbiological 
assessments included evaluation of total volume of colonizing bacteria (TVC) measured 
as CFU/ml., and obligate anaerobic bacteria, calculated by taking TVC minus the total 
colony counts on plates incubated in 10% CO2 (expressed as a percentage of TVC). Data 
was collected at baseline, day 21, day 90, day 180, and day 360 for both groups. Results 
of this study show similar results to the study by Ince et al. (2015), where the probiotic 
group had statistically significant changes in all clinical parameters and across all data 
collection intervals (p < 0.05). Similar evaluations were noticed on the probiotic group 
for TVC and obligate anaerobes, and across all data collection intervals except day 360. 
Researchers concluded L. reuteri containing lozenges may be a useful adjunctive therapy 
to SRP, to slow the recolonization of periodontal pockets (Tekce, 2015). Similar to the 
other studies using this product, the lozenges tested were provided by the company who 
makes them, BioGaia, AB, Lund, Sweden, although the researchers in this study claim 
there is no conflict of interest involved with this study, as the company was not involved 
in data management, but this could be a limitation of this research (Tekce et al., 2015). 
Topical Study Using Toothpaste. To date, studies involving the use of probiotic 
toothpastes are few, as this research methodology has not been well investigated, and 
only one study was found to discuss during this literature review. Results of a study by 
Amižić et al. (2016), showed brushing with probiotics as an application method is 
superior to mouthrinses at inhibiting common oral microbes, and set the stage for 
additional research regarding brushing with probiotics. Amižić et al. (2016) conducted a 
comparative study using two mouthrinses and two toothpastes. Although this study had 
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limitations including a complicated research design, after the results were revealed, the 
researchers concluded “Probiotic toothpaste, as a relatively new concept in the prevention 
of oral infectious diseases such as caries and periodontal disease, can contribute to the 
prevention of oral infectious diseases” (Amižić et al., 2016, p. 142). The aim of this 
study was to compare two toothpastes containing different strains of probiotics (one 
containing L. paracasei, and one containing L. acidophilus) and one toothpaste without 
probiotics separately, and in combination with two different mouthrinses (one containing 
essential oils, and the other containing Hexetidine). Hexetidine is a bactericidal and 
fungicidal antiseptic used as a 0.1% mouthwash for treating localized infections and oral 
hygiene (Aoun, Saadeh, & Berberi, 2015; National Center for Biotechnology  
Information, n.d). This study did not specify the number of participants involved in the 
study, or the length of the test period. According to the investigators, results of this study 
demonstrate probiotic toothpastes exhibited inhibition of Candida albicans (p = 0.043) 
and Streptococcus salivarius (p = 0.043) to a higher degree than toothpaste without 
probiotic. Across all the cases, toothpastes had stronger inhibition potential than 
mouthrinses (p < 0.05).  A stated limitation for this study by the investigators include the 
fact only a few specific bacteria were tested against agents in their pure form. The 
researchers suggest future studies should use toothpaste and mouthrinses with varying 
concentrations of agents on different microorganisms. This study may have additional 
limitations due to the unreported participant number and study length (Amižić et al., 
2016). 
Site Specific Introduction of Probiotics 
 
Research studies involving site specific introduction of probiotics into the oral 
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cavity are limited. Currently, no studies exist that have used humans as participants. A 
four-week study conducted by Teughels et al. (2007) used male Beagle dogs to test 
guided periodontal pocket recolonization (N = 8) and incorporated a split-mouth, double- 
blind, randomized method. The study design included four different treatments including 
negative control (Nc) = no treatment; positive control (Rp) = subgingival scaling and root 
planning; (Rp)single = root planning and a single application of bacterial mixture at 
baseline; (Rp)multi = root planning and repeated application of the bacterial mixture. Data 
was collected to evaluate subgingival plaque, probe depths, and BOP at baseline, weeks 
one, two, and four. Each dog received one of four treatments in each randomly chosen 
quadrant. Results of this research showed (Rp)multi was superior to all three other groups 
at reducing anaerobic species and black pigmented bacteria; (Rp)multi versus (RP) results 
were (p = 0.002 and p < 0.001), and (RP)multi when compared to (RP)single was (p = 0.03 
and p < 0.001). Conclusions of this study state due to the significant difference in the 
multiple treatment group, the research supports the concept that application of beneficial 
bacteria can lead to a more host-compatible periodontal environment, and in conjunction 
with scaling and root planning, may be a valid non-antibiotic approach to periodontal 
treatment (Teughels, 2007). Limitations of this study included concerns about beneficial 
bacteria being transferred to the control site, and the possibility that the application of 
probiotics induced an immunological response that interfered with the recolonization of 
the control sites (Teughels, 2007). 
Systematic Reviews and Meta-Analysis 
 
In the systematic review by Yanine et al. (2013), the stated objective was to 
analyze the available research on the effects of probiotics on periodontal diseases. After 
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eliminating several articles that did not meet stringent standards for inclusions criteria, 
the researchers were left with four articles, one using a topical approach with gum, and 
three using a systemic approach by means of a probiotic milk drink, and a tablet 
containing probiotics. The focus question was to determine the clinical impact on 
probiotic therapy compared to conventional and placebo treatments. Conclusions of this 
review state current research demonstrates probiotics have shown a slight benefit on PS 
and GI. They also determined more research is necessary to evaluate efficacy of 
probiotics utilizing correct methodology, larger population sizes, and longer trial periods 
(Yanine et al., 2013). 
In a review of the role of probiotics in oral health and the effects they induce on 
periodontal disease, Gupta & Gupta (2010) discuss methods of application of previous 
studies and limitations of these past study designs. In their analysis of available research, 
Gupta et al. (2010) point out the fact ingestion of probiotics does not provide prolonged 
contact time with oral tissues, facilitating probiotic adhesion to saliva coated surfaces, 
and recommend more research utilizing topical applications with prolonged contact be 
conducted (Gupta et al., 2010). In order to address these concerns, this study 
incorporated subjects brushing their teeth with a dentifrice with probiotic drops added. 
This method provided longer contact time, and brushing the gums with probiotics aided 
in adhesion, which these researchers have stated is a limitation in previous studies. 
Another review of current research by Teughels et al. (2011) examines studies on 
probiotics in the prevention and treatment of periodontal diseases. Their conclusions also 
discuss methodological limitations of previous studies and recommend an evaluation of 
the bacteria to be included in the probiotics used for a study. They recommend including 
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beneficial bacteria that are indigenous to the oral environment because they are perfectly 
adjusted to the oral ecology (Teughels et al. 2011). In this research study, the PI used 
probiotic drops containing L. reuteri, a probiotic bacteria common to the oral cavity, and 
commonly utilized in comparative research studies, in order to acknowledge this 
limitation (Iniesta, et al., 2012; Krasse et al., 2005; Sinkiewicz et al., 2010; Twetman et 
al., 2009; Vicario et al., 2013). 
Summary 
 
Probiotics are a beneficial remedy for several gastrointestinal aliments, and show 
encouraging results when applied to oral diseases (Amižić et al., 2016; Hallstrom et al., 
2013; Harini et al., 2010; Iniesta, et al., 2012; Karuppaiah et al., 2013; Krasse et al.,  
2005; Sinkiewicz et al., 2010; Slawik et al., 2011; Teughels, Newman et al., 2007; 
Twetman et al., 2009; Vicario et al., 2013; Yanine et al., 2013). One of the complications 
with evaluating the efficacy of probiotics for oral disease is the variety of application 
methods available for implementation. The oral environment is accessible for topical and 
site specific application, as well as systemic methods, whereas, the gastrointestinal tract 
can only utilize a systemic approach. Therefore, topical, systemic, and site specific 
applications have been used in research studies involving the oral cavity. This presents a 
dilemma for researchers when trying to ascertain the best methodology to incorporate,  
and has left many questions unanswered regarding application methods. 
This study attempted to determine the efficacy of brushing with probiotics as a 
means of application to the oral environment by evaluating the benefit of this method on 
a common oral disease, gingivitis. Research parameters evaluated included PS and GI 
(Amižić et al., 2016; Hallstrom et al., 2013; Harini et al., 2010; Krasse, et al., 2005; 
EFFICACY OF BRUSHING WITH PROBIOTICS 28  
 
 
Nadkemy et al., 2015; Noordin et al., 2007; Shah, 2014; Slawik et al., 2011; Sinkiewicz 
et al., 2013; Twetman et al., 2009; Yousuf et al., 2017). Previous research limitations 
such as study length and population demographics were addressed by implementing a 
longer study than many previous topical trials, and following a research design that 
employed a larger study population, increasing the chance for a more diverse population. 
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Methodology 
 
Research Method or Design 
 
This study was a randomized, placebo-controlled, double-blind design utilizing a 
convenience sample of participants from the population of students, faculty, and staff at 
the Spokane campus of Eastern Washington University (EWU), and friends and family 
members of the Principal Investigator (PI). The study period was three weeks in length, 
and had two data collection intervals; baseline, and week three (end of the study). 
Comparable research studies regarding topical application of probiotics have utilized 
treatment intervals of two to twelve weeks (Amižić et al., 2016; Hallstrom et al., 2013; 
Harini et al., 2010; Ince et. al., 2015; Krasse et al., 2005; Nadkemy et al., 2015; Noordin 
et al., 2007; Shah, 2014; Sinkiewicz et al., 2013; Tekce et al., 2015; Toiviainen et al., 
2015; Twetman et al., 2009; Vivekananda et al., 2010; Yousuf et al., 2017). Biological 
measurements of plaque accumulation were recorded using disclosing solution and an 
O’Leary PS, and gingival inflammation was recorded using a modified Löe-Silness GI 
(Karuppaiah et al., 2013; Slawik et al., 2011). Biological parameters in comparable 
studies have used these, and similar indices to evaluate gingivitis (Hallstrom et al., 2013; 
Harini et al., 2010; Iniesta et al., 2012; Karuppaiah et al., 2013; Slawik, et al., 2011). 
Procedures 
Human subjects protection/informed consent. In order to ensure protection of 
human subjects, the PI submitted a completed non-exempt application to the EWU 
Internal Review Board (IRB) prior to beginning the study. After IRB approval was 
obtained, the PI began recruiting participants for the study. During the screening process, 
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a detailed informed consent document (Appendix M) was given to each potential 
participant, and a signed copy was collected from each participant of this study. 
Participants were asked to be part of a 3-week clinical trial and agreed to the use either 
probiotic drops containing L. reuteri, or a placebo drop consisting of sunflower oil, added 
to a plain fluoride dentifrice. Participation was voluntary, and participants were informed 
they could drop out of the study at any time. Participants were also told if problems 
occurred during the study, they should bring them to the PI’s attention, and contact 
information for the PI was given to all participants. Confidentiality was maintained by 
assigning each participant a chart number, and all data collected was held by the PI in 
individual paper charts. HIPAA regulations regarding personal and health information 
were considered prior to beginning the study. Any identifiable information regarding 
participants of this study was blocked once participants had been accepted into the study, 
and a chart number was assigned to each participant. The PI kept all paper charts in a 
locked briefcase for transportation to and from the EWU dental hygiene clinic, where  
data collection took place. The locked briefcase was held at the PI’s personal residence, 
and remained locked when the PI was not using the information contained inside for 
study purposes. Data for statistical analysis was held in the PI’s personal computer, 
which is password protected. 
Informed consent (Appendix M) for this study considered all possible risks to the 
study participants, although the possibility of side effects or adverse reactions was 
considered low in view of the fact the probiotic drops used contained no common 
allergens such as milk protein or lactose, nuts, peanuts, soy, corn, gluten, wheat, eggs, 
fish, shellfish, artificial ingredients or flavors, and the administration of the probiotic 
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drops was topical. 
 
This study followed the guidelines established by the U. S. Food and Drug 
Administration (FDA) regarding dietary supplements. The FDA defines dietary 
supplements as products taken by mouth that contain a dietary ingredient, such as 
vitamins, minerals, amino acids, herbs, or botanicals, intended to supplement the diet 
(FDA, 2017). The FDA does not require regulation of dietary supplements, as they are 
deemed safe for use throughout the general public. The WHO describes probiotics as 
“live microorganisms that, when administered in adequate amounts, confer a health 
benefit on the host” (Venugopalan et al., 2010, p. 1661). The manufacturer of the 
probiotic drop does not make any health claims beyond the promotion of digestive and 
immune health, and as described by the WHO, probiotics have been determined to confer 
health benefits to the user. 
Informed consent included side effects or adverse reactions possible from 
engagement in the study as noted below: 
• Gastrointestinal upset, gas, bloating, diarrhea, nausea 
 
• Allergic reaction to fluoride or the plain fluoridated study toothpaste 
 
• Allergic reaction to sunflower oil, L. reuteri, or any component of the study or 
placebo drops 
Participants were advised how signs and symptoms of an allergic reaction may 
present as described below: 
• Gastrointestinal upset, gas, bloating, diarrhea, nausea 
 
• Oral conditions of the gums or oral tissues such as increased swelling, bleeding, 
tenderness, appearance of sores 
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• Burning sensation of oral tissues, tongue, or gums 
 
• Difficulty breathing, feeling of swelling of the throat/airway, wheezing, shortness 
of breath 
• Appearance of rash or hives 
 
Participants were advised of recommendations regarding intervention or treatment should 
any adverse reaction or side effect occur as detailed below: 
• Stop all study drops and toothpaste immediately if you experience any unusual 
signs or symptoms 
• Call the PI on her cell phone as soon as you notice any unusual symptoms or 
reactions 
• If you experience difficulty breathing, swelling of the throat/airway, wheezing, 
shortness of breath, rash or hives, call 911 immediately. As soon as possible, 
inform the PI of this study about the reaction, and discontinue use of the drops 
and study toothpaste. 
As an incentive to become a study participant and complete the full study term, all 
participants who completed the study received a $5 Starbucks gift card. Additionally, 
each person who completed the study was entered into a drawing for the chance to win a 
Sonicare electric toothbrush, donated by Jennifer Workman, Phillips Sonicare Senior 
Field Sales Representative for Spokane and Boise, or professional teeth whitening, 
including custom whitening trays and two syringes of whitening gel, courtesy of Dr. 
Truman Nielsen DMD at Fawson Dentistry. Participants who withdrew from the study 
early, and did not complete the full study term, were not eligible for these incentives. 
Criteria for sample selection. Inclusion criteria included healthy adults between 
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the ages of 18 and 65 with no systemic diseases or chronic illnesses (see Appendix D), 
willing to provide detailed information regarding their health, medications and known 
allergies, and ability to complete the entire study. Comparable studies where L. reuteri 
has been ingested have incorporated a four-week (30 day) washout period to ensure no 
residual benefits from the ingested probiotics remain (Iniesta et al., 2012). Therefore, for 
one month prior to the beginning of the study, and during the study, subjects could not be 
taking any antibiotics or using probiotic tablets. Additionally, participants were asked to 
consume only limited amounts (3 times per week or less) of foods and beverages 
containing probiotics (Iniesta et al., 2012; Vicario et al. 2013) (Appendix I). Inclusion 
criteria also called for subjects to have at least 20 evaluable teeth (Nadkemy et. al., 2015) 
and exhibit gingivitis. 
Participants were assessed through a screening process prior to beginning the 
study to determine whether they had gingivitis. Participant screenings took place in the 
dental hygiene clinic at EWU or the PI’s private practice office, located in Spokane, 
Washington. Clinical parameters of plaque accumulation and gingival inflammation 
were assessed with a PS (Appendix C) and GI (Appendix B). Exclusion criteria 
dismissed people who were using nicotine gum or lozenges, electronic cigarettes or 
vaping devices, chewing tobacco, smoking tobacco in any form; cigars, cigarettes, pipes, 
smoking marijuana or hookah, or using marijuana sublingual drops, and anyone using 
chlorhexidine oral rinse solutions (Sinkiewicz et al., 2010). Use of edible and non- 
smoking forms of marijuana were permissible for the study, as was the use of nicotine 
patches (Appendix I). 
Description of the setting. This study was conducted in the dental hygiene clinic 
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at EWU, Spokane, Washington. This location was selected for pragmatic purposes, as 
the PI is affiliated with EWU and it had facilities to support screening and data collection 
of study subjects. All screenings and data collection were scheduled during times when 
the EWU clinic was not in use for academic purposes, and participation by any current 
faculty, staff, or students of EWU was voluntary, and took place outside of the 
volunteers’ regular work hours. 
Source. A convenience sample of participants was obtained for this study drawing 
from the faculty, students, and staff at the EWU Spokane campus, and co-workers,  
friends and family members of the PI. This sample provided the variety in age, ethnicity, 
gender, and demographics required for application to a larger population. Sample 
selection for this study consisted of individuals responding to a flyer posted at various 
sites on the Spokane campus of EWU (Appendix J), and through social media blasts 
entered onto the PI’s personal social media accounts to alert the PI’s co-workers, friends, 
and family of the study. The flyer used was approved for display by EWU prior to 
recruitment, and the social media blast was placed on Facebook, using a modified version 
of the recruitment flyer (Appendix J). 
Plan. The design of this study was modeled after comparable clinical trials, and 
participants were evaluated at the beginning of the study (baseline data collection) and at 
end of week three (final data collection) (Vicario et al., 2013). Each participant was 
randomly divided into one of two groups: Group A or Group B. During the screening 
process, the research coordinator (RC) randomly assigned a drop to each participant, 
alternating the dispensing of Drop A and Drop B to ensure equal distribution of each type 
of drop. Participants given Drop A were said to be in Group A, and participants given 
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Drop B were said to be in Group B. The study began with a screening for each individual 
wanting to be a participant, and baseline data was collected at this time for the clinical 
parameters being evaluated. After baseline data was recorded, participants were assigned 
their study drops to add to their study toothpaste, and given a schedule of the study 
(Appendix G) to track their daily usage of toothpaste with drops. Participants were asked 
to check off each day of use on the schedule. The schedule also included designated days 
for data collection, to remind participants when to return for clinical assessments 
(Appendix G). The PI requested participants bring the schedule to the final data 
collection at the end of week three to confirm participation. Each participant was given a 
laminated study reminder card (Appendix L) outlining important information about the 
use of the drops and toothpaste. This card also served to help them remember to use their 
drops and toothpaste once a day. 
Subjects were asked to undergo a screening process to confirm they met inclusion 
criteria for study enrollment. The screening process include filling out a printed version 
of the current health history form used in the EWU Dental Hygiene Clinic, containing 
questions on demographic and health information (Appendix E). This health history is 
part of Eaglesoft©, the electronic health record (EHR) software utilized at EWU. 
Participants were also asked to fill out a survey on recent usage of probiotics, antibiotics, 
and known allergies (Appendix F). An evaluation of the mouth to assess oral health 
status and existence of gingivitis was performed by using a modified Löe-Silness GI 
(Appendix B) to assess gingival inflammation, and an O’Leary PS (Appendix C) to 
assess plaque levels. 
During the duration of the study, participants were instructed to use limited 
EFFICACY OF BRUSHING WITH PROBIOTICS 36  
 
 
amounts (3 or less times per week) of any food or beverage on the excluded foods list 
(Appendix I), and not to use any medications, over the counter remedies such as 
probiotics, or engage in the use of any excluded habits or recreational substances 
(Appendix D) including: 
• Chewing tobacco, and Smoking tobacco products such as cigarettes, cigars, pipes 
 
• Nicotine products used orally such as gum or lozenges 
 
• Electronic cigarettes or vaping devices 
 
• Hookah 
 
• Smoking marijuana 
 
• Marijuana sublingual drops 
 
Participants of this study visited the EWU Dental Hygiene clinic a total of two times for 
initial screening and data collection, and all participants were given a schedule with data 
collection dates, times, and detailed information on when to use drops (Appendix G). 
Participants of the study were given a plain, fluoridated toothpaste to use during 
the study period. The plain toothpaste provided during the study contained no triclosan, 
xylitol, whitening or tartar control additives. Other comparable studies have used 
fluoride mouthwash, and xylitol, in conjunction with the probiotic treatment remedies 
without concern for bioavailability of the probiotics, therefore, use of a plain fluoridated 
toothpaste in this study was not contraindicated (Amižić et al., 2016; Shah, 2014; 
Toiviainen et al., 2015). Along with the assigned toothpaste, participants were given a 
vial of liquid containing either probiotics, or organic sunflower oil (placebo), the main 
component of the probiotic drop used during the study. The probiotic drops used for this 
study were obtained through the online shopping website Amazon.com. These drops are 
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manufactured in Canada by Bioamicus Laboratories® and contain 2 x 10
8 
CFU of the 
probiotic L. reuteri per 5 drops, and contain no milk protein or lactose, nuts, peanuts, soy, 
corn, gluten, wheat, eggs, fish, shellfish, artificial ingredients or flavors. The original use 
of this drop is as an oral drop to promote digestive and immune health for infants and 
children. Dosage is described as: 
Infants and children age 0 – 3, use 5 drops once per day 
 
Adults, adolescence, and children age 4 or older, use 5 drops one to three times 
per day 
Comparable research utilized L. reuteri, with similar dosages as used in this study 
(Vicario et al., 2013). 
Participants were instructed not to alter their normal homecare routine, and use 
only the assigned study toothpaste when brushing (Sinkiewicz et al., 2010; Vicario et al., 
2013). Additionally, they were instructed to add 5 drops of their assigned drops to their 
toothbrush, then add the desired amount of study toothpaste, and brush per their normal 
routine. It was important the vial of drops be refrigerated to maintain the live active 
probiotic cultures contained in the drops, so participants were instructed to keep the vial 
of drops refrigerated when not being used, and to shake the drops well before use to 
ensure no separation of ingredients. 
Due to the number of participants (N = 34), and the complexity of this research 
study, the PI enlisted volunteers. The source for these volunteers were the PI’s 
colleagues, and fellow graduate and undergraduate students from the EWU Dental 
Hygiene Department. Participation was voluntary, and no compensation was given to 
volunteers. Volunteers helped outside of their regular work hours, and were able to 
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attend all screenings and data collection dates, in order to maintain consistency in data 
collection. The PI enlisted help from two research assistants, three clinical assistants, and 
a research coordinator to help implement this clinical trial. 
Research Assistants (RA) were registered dental hygienists (RDH) holding an 
active license in the state of Washington and had an active professional liability insurance 
policy. The RAs and the PI, conducted the clinical assessments and data collection  
during screenings. To ensure interrater reliability, RAs received calibration and training 
materials, an orientation on the use of study forms, and a brief question and answer 
session prior to any screening or data collection. (Appendix K). Research assistants were 
in charge of administering informed consent to study participants, and obtaining a signed 
informed consent document from them. Therefore, RAs completed the Collaborative 
Institutional Training Initiative (CITI) prior to beginning the research study to comply 
with IRB regulations regarding the handling of informed consent for research subjects. 
Clinical Assistants (CA) helped with recording data collection, cleaning and 
sterilization of instruments, and dental unit set-up, break-down, and disinfection. CAs 
had a brief training session prior to screening and data collection to ensure interrater 
reliability (Appendix K). The Research Coordinator (RC) was responsible for randomly 
assigning the study drops to the participants, coordinating the CAs and helping CAs with 
their duties when needed, and handing out study packets to participants, containing study 
drops, toothpaste, schedule, and reminder card. 
The PI enlisted a person outside the study, called the study contractor (SC) to 
prepare the study drops. The SC prepared both the probiotic and placebo drops by using 
sterile pipettes to transfer either the Bioamicus probiotic drops, or organic sunflower oil, 
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into sterile, identically appearing pharmaceutical vials with self sealing caps. The SC 
randomly numbered each drop, recording the numbers into a log, identifying the group 
the drop fell into, and maintained this information in a separate password protected 
computer from the PI’s computer throughout the study period. When the study was 
complete, the SC released the information to the PI regarding the drop numbers included 
in the probiotic (test) or placebo (control) groups. This anonymous random design kept 
the participants, RAs, CAs, RC, and PI from knowing which groups were test or control, 
ensuring the study followed a randomized, double-blind design. 
Size. This study had 34 participants (N = 34) consisting of 11 males (n = 11) and 
23 (n = 23) females. Comparative research utilized between 18 and 45 subjects, with 
predominately female participants (Hallstrom et al., 2013; Harini et al., 2010; Iniesta et 
al., 2012; Slawik et al., 2011; Twetman et al., 2009). According to research conducted by 
Chan (2003), when paired samples are being analyzed using the pre and post mean 
difference of two treatment groups, a simple formula can be used to determine the 
statistically significant sample size: Total sample size = c/δ2 + 2 (Chan, 2003). 
For this study to have 80% power with a 95% confidence level, 34 participants were 
needed (Chan, 2003). 
Variables. This study evaluated the dependent variables of plaque levels and 
gingival inflammation for each participant (Krasse et al., 2005). Plaque levels were 
determined by using a PS (Appendix C). Inflammation of the gingival tissues was 
assessed through use of a GI (Appendix B) (Karuppaiah et al., 2013; Shah, 2014; Slawik, 
et al., 2011). Independent variables for this study were placebo and probiotic drops. The 
PI examined the outcome of baseline versus final data on these variables to ascertain if 
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brushing with probiotics added to toothpaste significantly reduced PS and GI more than 
brushing with a placebo added to toothpaste. 
Instruments. Quantitative data included a PS using the O’Leary PS (Appendix 
 
C) (Conn, Warren-Morris, Prihoda, Hicks, & Hernandez, 2017) and a GI using a 
modified Löe-Silness GI (Appendix B) (Karuppaiah et al., 2013; Slawik, et al., 2011). 
To address concerns with reliability and validity of PS assessments, 2Tone
TM 
brand 
disclosing solution was used to expose participant’s plaque. This disclosing solution 
helps to differentiate plaque accumulation by staining new plaque pink and mature plaque 
purple. RAs were instructed to only record the purple, or mature plaque, for plaque 
scores. In order to ensure validity and reliability of the GI index used, the PI utilized a 
modified GI. Modification included changing a traditional Löe-Silness gingival index 
with a scale of 0, 1, 2, 3 to a 1, 2, 3 scale, thus changing the scale to a bleed or no bleed 
evaluation. The modified scale incorporates information and suggestions from Dr. 
Aldredge regarding bleeding on probing defined (Aldredge, 2012). Original Löe-Silness 
index parameters have number 0 and 1 as no bleeding, and instead examine differences in 
color, consistency, and contour of gingival tissue to determine a score of 0 or 1. The PI 
was concerned with reliability of data collected with the original index, as this evaluation 
can be subjective and vary between examiners. The modified index assigned a 1 for no 
bleeding, and bleeding was divided into a score of 2, equaling slight bleeding, or 3, 
equaling moderate to heavy bleeding (Appendix A). 
Equipment. The PI requested and obtained permission from the Chair of the 
Dental Hygiene Department at EWU to use the dental hygiene clinic for this research 
study. Equipment and use of the dental hygiene clinic at EWU was borrowed or donated 
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through an in-kind donation by the EWU Dental Hygiene Department including use of 
clinic/office printers, paper, laminating machine, dental chairs, dental units, disposable 
barriers, disposable personal protective equipment (masks, gloves), disposable sundries 
(paper towels, gauze, cups, cotton tip applicators), and basic instrument sets: including a 
mirror, air/water syringe tip, and periodontal probe. The PI supplied disclosing solution, 
individual vials of placebo drops or probiotic drops for study participants, instructional 
material for participants, informed consent for participants, forms to record parameters of 
plaque (Appendix C) and gingival inflammation (Appendix B). 
Steps to implementation. 
 
1. Applied for IRB research study approval 
 
2. Arranged screening dates with faculty and staff of the EWU Dental 
Hygiene Department to screen for study participants 
3. Arranged data collection dates with faculty and staff of the EWU Dental 
Hygiene Department 
4. Printed recruitment flyers for study participants 
 
5. Hung recruitment flyers around the EWU Campuses 
 
6. Sent out a Facebook social media blast to PI’s friend’s and family seeking 
participants for the study and using a similar recruitment flyer as 
demonstrated in Appendix J 
7. Recruited registered dental hygienists to be research assistants to help 
gather data 
8. Recruited a research coordinator 
 
9. Recruited clinical assistants 
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10. Calibrated all RAs and CAs (Appendix K). 
 
11. Held screenings to choose study participants 
 
12. Prepared all vials of probiotic and placebo drops 
 
13. Prepared labels for probiotic and placebo drops 
 
14. Had the SC assign numbered labels to drops and record the numbers, and 
groups, into an Excel© 2015 spreadsheet, and hold this information 
confidential until the end of study 
15. Implemented the study on first selected data collection date 
 
Summary 
 
Probiotics present an exciting new approach for dentistry in the management of 
oral disease. Current research shows promising results using probiotics administered 
through several different mediums in the oral cavity. Results from these studies has been 
inconclusive and call for further research to determine the best means of application to 
the oral environment (Gupta et al., 2010; Hallstrom et al., 2013; Harini et al., 2010; 
Iniesta et al., 2012; Karuppaiah et al., 2013; Meurman, 2005; Yanine et al., 2013). Most 
researchers agree future studies involving probiotics for the treatment and prevention of 
oral diseases should strive to identify proper strains for specific diseases, application 
methods, dosages, and duration of use (Gupta et al., 2010; Meurman, 2005; McFarland, 
2015; Teughels et al., 2011; Yanine et al., 2013). This study sought answers to these 
questions by utilizing toothbrushing as the application method, as few studies exist 
incorporating brushing as an application method. 
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Results 
 
Description of Sample 
 
This study had 34 participants (N = 34) consisting of 11 males and 23 females 
(Fig. 2). Comparative research utilized between 18 and 45 subjects, with predominately 
female participants (Hallstrom et al., 2013; Harini et al., 2010; Iniesta et al., 2012; Slawik 
et al., 2011; Twetman et al., 2009). According to research conducted by Chan (2003), 
when paired samples are being analyzed using the pre and post mean difference of two 
treatment groups, a simple formula can be used to determine the statistically significant 
sample size: Total sample size = c/δ2 + 2 (Chan, 2003). 
For this study to have 80% power with a 95% confidence level, 34 participants were 
needed (Chan, 2003). 
 
 
 
23 
 
 
 
 
 
 
 
11 
 
 
 
 
 
 
 
Males Females 
 
Figure 2. Gender (N = 34) 
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Diversity among different ethnic groups include three different ethnicities, although 
numbers were small for some groups. 
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White/Caucasian Hispanic Asian 
 
Figure 3. Ethnicity (N = 34) 
 
This study did have a wide distribution of ages represented in the sample of participants, 
and included individuals from age 20 to 64. Ages were divided into four age ranges. 
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Figure 4. Age Ranges (N = 34) 
EFFICACY OF BRUSHING WITH PROBIOTICS 45  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Participant compliance for this study was 100% with no included participants dropping 
out of the study. Figure 5 shows the percentage of participants who used their drops 
every day of the study, in comparison to participants who missed one to four days, and 
five or more days during the study period. 
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Figure 5. Participation Compliance Rate. Number of missed days. (N = 34) 
 
Statistical Analysis 
 
The study hypothesis claimed brushing with L. reuteri probiotic drops added to a 
plain fluoride dentifrice would result in a statistically significant decrease in the clinical 
parameters of gingivitis compared to brushing with a placebo drop added to the same 
type of toothpaste. All study participants exhibited some stage of gingivitis, either 
localized or generalized. Clinical parameters of gingivitis were observed and measured 
through the use of a GI to assess gingival inflammation, and PS, to evaluated plaque 
accumulation. 
The PI entered all data into Excel
© 
2015 and transfer it to IBM
® 
SPSS
®
 
 
(Statistical Package for Social Sciences) Version 24 for analysis (Karuppaiah et al., 2013, 
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Vicario et al., 2013). Analysis included both descriptive and inferential statistics. 
Inferential statistics employed Wilcoxon Signed Rank tests, due to the small sample size 
and inability to assume normal distribution of the study population. Statistical 
significance level was set at p < 0.05 (Imam, Mohammed, & Abanyam, 2014). Variables 
included median differences between the probiotic and placebo groups’ baseline and final 
data for both PS and GI (Table 1, Table 2). Comparisons were also made by age and 
gender (Table 3, Table 4, Table 6, Table 7), and to evaluate the difference between final 
PS for placebo versus probiotic (Table 5) and final GI for placebo versus probiotic (Table 
5). Table 8 evaluates difference in the number of participants with dental affiliations 
based on gender, and Table 9 evaluates differences in dental affiliations between the 
probiotic and placebo groups. 
Table 1 depicts the placebo group’s significance level between the beginning of 
the study (baseline) and week three (final) data. As noted in the table, differences in PS 
were not significant, although differences in GI did show a statistical significance. 
Table 1 
  Placebo Group Baseline vs Final Data     
Null Hypothesis Test Sig. Decision 
PS The median of differences 
between Baseline PS and 
Final PS equals 0 
Related samples 
Wilcoxon Signed 
Rank Test 
.394 Retain the null 
hypothesis 
 
 
GI The median of differences 
between Baseline GI and 
Final GI equals 0 
Related samples 
Wilcoxon Signed 
Rank Test 
.001 Reject the null 
hypothesis 
Note. Sig. = significance. PS= Plaque Score. GI= Gingival Index. 
Asymptomatic significances are displayed 
The significance level is p < 0.05 
 
Table 2 depicts the probiotic group’s significance level between the beginning of the 
study (baseline) and week three (final) data. As noted in the table, differences in both PS 
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and GI were not significant. 
 
Table 2 
  Probiotic Group Baseline vs Final Data     
Null Hypothesis Test Sig. Decision 
PS The median of differences 
between Baseline PS and 
Final PS equals 0 
Related samples 
Wilcoxon Signed 
Rank Test 
.352 Retain the null 
hypothesis 
 
GI The median of differences 
between Baseline GI and 
Final GI equals 0 
Related samples 
Wilcoxon Signed 
Rank Test 
.485 Retain the null 
hypothesis 
Note. Sig. = significance. PS= Plaque Score. GI= Gingival Index. 
Asymptomatic significances are displayed 
The significance level is p < 0.05 
 
Table 3 shows the placebo group’s significance level between the beginning of the study 
(baseline) and week three (final) data by age group. No statistically notable differences 
in PS or GI were demonstrated for any age group. 
Table 3 
  Placebo Group Baseline vs Final Data by Age   
 Null 
Hypothesis 
Test Age Sig. Decision 
PS The median of Related 18-29 .465 Retain the 
 differences samples 30-39 .225 null 
 between Wilcoxon 40-49 .593 hypothesis 
 Baseline PS 
and Final PS 
Signed 
Rank Test 
50-65 .225  
 equals 0     
 
GI The median of Related 18-29 .068 Retain the 
 differences samples 30-39 .080 null 
 between Wilcoxon 40-49 .109 hypothesis 
 Baseline GI 
and Final GI 
Signed 
Rank Test 
50-65 .068  
 equals 0     
Note. Sig. = significance. PS= Plaque Score. GI= Gingival Index. 
Asymptomatic significances are displayed 
The significance level is p < 0.05 
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Table 4 shows the probiotic group’s significance level between the beginning of the study 
(baseline) and week three (final) data by age group. No statistically notable differences  
in PS or GI were demonstrated for any age group. 
Table 4 
  Probiotic Group Baseline vs Final Data by Age   
 
 
PS 
Null 
Hypothesis 
Test 
Related 
Age 
18-29 
Sig. 
.197 
Decision 
Retain the 
 The median of samples 30-39 .068 null 
 differences Wilcoxon 40-49 .655 hypothesis 
 between Signed 50-65 .249  
 Baseline PS 
and Final PS 
equals 0 
Rank Test    
GI The median of Related 18-29 .893 Retain the 
 differences samples 30-39 .593 null 
 between Wilcoxon 40-49 .465 hypothesis 
 Baseline GI 
and Final GI 
Signed 
Rank Test 
50-65 .465  
 equals 0     
Note. Sig. = significance. PS= Plaque Score. GI= Gingival Index. 
Asymptomatic significances are displayed 
The significance level is p < 0.05 
 
Table 5 compares differences between the final data of the placebo versus probiotic 
group. As seen in the table, no significant differences were observed. 
Table 5 
Probiotic vs Placebo Final Data 
Null Hypothesis Test Sig. Decision 
PS The median of differences 
between Baseline PS and 
Final PS equals 0 
Related samples 
Wilcoxon Signed 
Rank Test 
.586 Retain the null 
hypothesis 
 
GI The median of differences 
between Baseline GI and 
Final GI equals 0 
Related samples 
Wilcoxon Signed 
Rank Test 
.177 Retain the null 
hypothesis 
Note. Sig. = significance. PS= Plaque Score. GI= Gingival Index. 
Asymptomatic significances are displayed 
The significance level is p < 0.05 
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Table 6 shows the placebo group’s significance level between the beginning of the study 
(baseline) and week three (final) data by gender. No statistically notable differences in 
PS or GI were demonstrated for males, or for females in regard to PS, but females did 
show a statistical difference in GI. 
Table 6 
Placebo Baseline vs Final Data by Gender 
 
 
 
PS 
Null Hypothesis 
The median of 
Test 
Related samples 
Gender 
Male 
Sig. 
.686 
Decision 
Retain the null 
 differences between Wilcoxon Signed   hypothesis 
 Baseline PS and Final Rank Test    
 PS equals 0  Female .505 Retain the null 
     hypothesis 
 
GI The median of 
differences between 
Baseline GI and Final 
GI equals 0 
Related samples 
Wilcoxon Signed 
Rank Test 
Male 
 
 
 
Female 
.068 
 
 
 
.004 
Retain the null 
hypothesis 
 
Reject the null 
hypothesis 
Note. Sig. = significance. PS= Plaque Score. GI= Gingival Index. 
Asymptomatic significances are displayed 
The significance level is p < 0.05 
 
Table 7 shows the probiotic group’s significance level between the beginning of the study 
(baseline) and week three (final) data by gender. No statistically notable differences in  
PS or GI were demonstrated for either gender. 
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Table 7 
  Probiotic Baseline vs Final Data by Gender   
 
 
PS 
Null Hypothesis 
The median of 
Test 
Related samples 
Gender 
Male 
Sig. 
.753 
Decision 
Retain the null 
 differences between Wilcoxon Signed   hypothesis 
 Baseline PS and Final 
PS equals 0 
Rank Test  
Female 
 
.445 
 
Retain the null 
     hypothesis 
GI The median of Related samples Male .463 Retain the null 
 differences between Wilcoxon Signed   hypothesis 
 Baseline GI and Final Rank Test    
 GI equals 0  Female .721 Retain the null 
     hypothesis 
Note. Sig. = significance. PS= Plaque Score. GI= Gingival Index. 
Asymptomatic significances are displayed 
The significance level is p < 0.05 
Table 8 illustrates the percentage of participants in the placebo group working or 
studying in the dental field by gender versus those without any dental affiliations. 
Table 8 
  Placebo Group Females vs Males Dental Affiliation   
Dental Affiliation Number Percent of 
Total 
%With Aff 
67% of group 
% Diff bet 
Groups 
Females Student  4 
Works in  4 
dentistry 
No Affiliation  4 
Males Student 0 
Works in  2 
dentistry 
No Affiliation  3 
33.33% 
33.33% 
 
33.33% 
 
 
 
 
 
0.00% 
40% 
 
60% 
had dental 
affiliations 
 
 
 
 
 
 
 
 
40% of group 
had dental 
affiliations 
Females had 
a 27% 
greater 
number of 
participants 
with dental 
affiliations 
 
Note. % With Aff = the total percentage of the group with dental affiliations. %Diff bet Groups = 
difference in percentage of participants with no dental affiliation between females and males. 
 
Table 9 illustrates the percentage of participants in the placebo and probiotic group who 
work or study in the dental field versus those without any dental affiliations. The table 
indicates the difference, in percentage, between these groups of individuals with dental 
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 Dental Affiliation Number Percent of %With Aff % Diff bet 
 
 
Placebo 
 
 
Student 
 
 
4 
Total 
23.53% 
35.29% 
59% of group 
had dental 
affiliations 
Groups 
Placebo 
 
 
 
affiliations. 
 
Table 9 
  Placebo vs Probiotic Group Dental Affiliation   
 
 
 
 
 
Works in  6 
dentistry 
No Affiliation  7 
Probiotic Student  3 
Works in  5 
dentistry 
No Affiliation  9 
 
 
 
41.18% 
 
 
 
 
 
17.65% 
29.41% 
 
52.94% 
 
 
 
 
 
 
 
 
 
47% of group 
had dental 
affiliations 
group had a 
12% greater 
number of 
participants 
with dental 
affiliations 
 
Note. % With Aff = the total percentage of the group with dental affiliations. %Diff bet Groups = 
difference in percentage of participants with no dental affiliation between placebo and probiotic groups. 
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Discussion 
 
Summary of Major Findings 
 
During this study, median differences between the probiotic and placebo groups’ 
baseline and final data for both PS and GI were analyzed to answer the research question: 
Will brushing with toothpaste and L. reuteri probiotic drops reduce clinical 
parameters of gingivitis in healthy adults in comparison to brushing with 
toothpaste and placebo drops? 
Data collection showed individual response to the treatment was inconclusive, with some 
participant’s plaque accumulation and gingival inflammation exhibiting reductions, 
whereas others increased. Statistical analysis revealed the only statistically significant 
differences were the GI of the placebo group as a whole (p = 0.001) and females from the 
placebo group (p = 0.004) (Table 1 and Table 6). 
Additional comparisons were made by age and gender (Table 3, Table 4, Table 6, 
Table 7), and to evaluate the difference between final PS for placebo versus probiotic 
(Table 5) and final GI for placebo versus probiotic (Table 5), all showing no statistically 
significant differences between beginning to end of study data. Evaluation was also 
performed to compare differences in the number of participants with dental affiliations 
based on gender (Table 8), and differences in dental affiliations between the probiotic and 
placebo group (Table 9). 
Discussion 
 
Plaque score results. Results from this study showed comparable findings to 
research conducted by Iniesta et al. (2012) where no statistically significant difference 
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was observed in plaque accumulation between baseline and end of study data for both the 
test (probiotic) and control (placebo) groups. This result is also consistent with 
comparable research conducted by Krasse et al. (2005), Sinkiewicz et al. (2013), and 
Slawik et al. (2011), showing PS between visit one and visit two of the test group to be 
non-significant (Iniesta et al., 2012; Krasse et al., 2005; Sinkiewicz et al., 2013; Slawik et 
al., 2011). PS results from this current study actually showed increased plaque 
accumulation in both the test and control groups, similar to the L. reuteri lozenge study 
conducted by Hallstrom et al. (2013) where all subjects at the end of the study presented 
with an increase in plaque accumulation and gingival inflammation (Hallstrom et al., 
2013). Prior to the beginning of this study, the PI assumed PS would not decrease as a 
result of brushing with probiotics, as plaque accumulation seemed to be non-significant, 
or increase, in most of the probiotic studies reviewed (Hallstrom et al., 2013; Iniesta et  
al., 2012; Krasse et al., 2005; Sinkiewicz et al., 2013; Slawik et al., 2011). 
The PI of this study surmises one reason for this outcome could be the shorter 
duration of time for this study, as this study lasted only three weeks. Longer clinical 
studies have resulted in PS that did show statistically significant differences between test 
and control groups from beginning to end of study (Noordin et al., 2007; Shah, 2014; 
Tekce et al., 2015; Toiviainen et al., 2015; Vivekananda et al., 2010). Another possible 
reason for this result could have been the lower concentration of probiotic used in this 
study, the frequency of use each day of the probiotic in comparison to similar studies, and 
participant compliance to the treatment regimen (Krasse et al., 2005; Sinkiewicz et al., 
2013; Tekce et al., 2015; Toiviainen et al., 2015; Vivekananda et al., 2010). This study 
utilized either placebo or probiotic drops added to the participant’s toothbrush prior to 
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toothpaste once per day. The probiotic used in this study was L. reuteri with a probiotic 
concentration of 1 x 10
8 
CFU per dose. Compliance with the treatment regimen of once 
per day use for this study by participants was 62% (n = 21). Iniesta et al. (2012) utilized 
a once per day treatment regimen for their systemic probiotic study with 100% 
compliance for the treatment regimen. Participants (N = 40) in Iniesta et al. (2012) were 
asked to take a tablet once per day for four week containing either a placebo, or two 
different strains of L. reuteri with probiotic levels of 2 x10
8 
CFU per tablet. These 
researchers observed comparable results to this study, with no significant change in PS 
between baseline and final data (Iniesta et al., 2012). They attribute this to the short 
duration of the study, and sample population being dental students. 
Probiotic studies utilizing similar or higher concentrations of probiotics, with 
usage two or more times per day, demonstrated improved PS in the treatment group at the 
end of the study. In the topical probiotic study by Krasse et al. (2005), probiotic gum was 
chewed two times each day by the subjects, with a concentration of 1 x 10
8 
CFU for each 
piece of gum. A similar study by Sinkiewicz et al. (2013) had subjects using chewing 
gum with 2 x 10
8 
CFU per gum twice daily. Lozenge studies with similar probiotic 
concentration to Krasse et al. (2005) and Sinkiewicz et al. (2013) had subjects using the 
lozenges two to three times a day (Tekce et al., 2015; Toiviainen et al., 2015; 
Vivekananda et al., 2010). This study may have seen an equivalent reduction in PS had a 
higher concentration of probiotic drop been used, and the frequency were more than one 
time per day (Krasse et al., 2005; Sinkiewicz et al., 2013; Tekce et al., 2015; Toiviainen  
et al., 2015; Vivekananda et al., 2010). 
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Gingival inflammation results. Prior to the beginning of this study, the PI  
hoped brushing with probiotics added to toothpaste would promote application of 
probiotics into the oral environment. Gupta et al. (2010) discussed the relevance of 
application method and contact time in their systematic review, and recommended more 
research utilizing topical applications with prolonged contact. In their analysis of 
available research, Gupta et al. (2010) suggest ingestion of probiotics does not provide 
prolonged contact with oral tissues, facilitating probiotic adhesion to saliva coated 
surfaces (Gupta et al., 2010). In a topical study by Amižić et al. (2016), comparisons 
were made between two different toothpastes containing probiotics, plain toothpaste, and 
two different antimicrobial mouthrinses. Results of this study revealed probiotic 
toothpaste to have better inhibitory effects than toothpaste without probiotics. 
Additionally, this study showed toothpaste to have stronger inhibition properties than 
mouthrinses (Amižić et al., 2016). Therefore, the PI theorized the action of brushing 
might improve adherence to the existing mature biofilm, and prolong the contact time of 
probiotics to oral tissues. The expected outcome was a decrease in gingival inflammation 
due to improved adherence and application time. Actual results of this study did not 
corroborate this theory. As previously mentioned, the PI attributes this to frequency of 
treatment application, thereby resulting in a therapeutic level of the test agent not being 
achieved, and possibly participant compliance, as some participants did not brush daily 
with their assigned drops. This lack of compliance would have resulted in even less 
therapeutic agent being administered to these individuals throughout the study period. 
Results of this study comparing GI baseline versus final data showed no 
significant difference for the probiotic (test) group (p = 0.485) (Table 2). Conversely, the 
EFFICACY OF BRUSHING WITH PROBIOTICS 56  
 
 
placebo group (control) did show statistically significant differences from the beginning 
to final scores (p = 0.001) (Table 1). This was an unexpected result the PI attributes to 
participation bias. The placebo group had 59% of the participants with dental affiliations, 
where participants were dental hygiene students, or worked in the dental field. The 
probiotic group had 47% of participants with similar dental affiliations. Having dental 
affiliations would afford these participants a higher level of dental knowledge, and may 
have made these participants more aware of their oral health status when baseline data 
was collected. The PI surmises this may have led to an unintentional improvement in 
these participants previous homecare, resulting in improvements in their GI when 
comparing baseline versus final data. The results for females in the placebo group (Table 
6) were statistically different (P = 0.004) as compared to males in this group. The female 
population of the placebo group had a 27 % greater number of participants with dental 
affiliations. Therefore, the females in the placebo group had a perceived greater 
knowledge of the data collection process, and were more likely to exhibit an  
unintentional participation bias. This difference may have been enough to account for the 
statistically relevant difference between females and males GI scores in the placebo 
group. 
Observer bias may have also effected the outcome of the placebo group’s GI. 
Research assistants collecting data may have been expecting to see improved results in 
participants, and overestimated their oral health when collecting final data, causing lower 
GI scores to be recorded for some participants. In order to produce a statistically 
significant difference in GI when comparing baseline to final data, it is possible a 
combination of both participation and observer bias may have contributed to the placebo 
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group’s results. Shimauchi et al. (2008) also postulates participation bias may have 
altered the findings of their 2008 study, since the only statistically significant difference 
in clinical parameters for this study were in a small subgroup of participants who were 
smokers. This subgroup noticed a decrease in PS as compared to all other groups 
(Shimauchi et al., 2008). 
Research studies seeking to determine changes in the clinical parameter of 
gingival inflammation, have had mixed outcomes. Several systemic and topical 
application studies have been able to demonstrate statistically significant differences in  
GI (Harini et al., 2010; Nadkemy, 2015; Noordin et al., 2007; Karuppaiah et al., 2011; 
Tekce et al., 2015; Toiviainen et al., 2015; Vivekananda et al., 2010; Yousuf et al., 2007). 
Although findings of this study were not as originally expected, and no significant 
differences in GI could be noted, other studies evaluated in the literature review for this 
study have similar conclusions. Systemic probiotic studies by Iniesta et al. (2012), 
Montero et al. (2017), and Shimauchi et. al. (2008) all had no significant change in GI 
between baseline and final data. Studies utilizing topical introduction of probiotics have 
also had some unexpected results. Research by Shah (2014), and Hallstrom et al. (2013) 
also presented discouraging outcomes due to results not demonstrating significant 
differences in the placebo or probiotic groups GI (Hallstrom et al., 2013; Shah, 2014). 
The PI of this study speculates the study limitations of a short study duration, in 
conjunction with the lower overall amount of therapeutic agent applied, may have 
contributed to GI results not being statistically significant. Participation compliance was 
less than 60% for this study, and the study design of using the drops once per day was 
less than many similar studies that used therapy application two to three times per day. 
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Limitations 
 
As with all research, the question of attention or participation bias, also known as 
the Hawthorne Effect, is a notable possible limitation. This phenomenon occurs when it 
appears changes in behavior of research participants may be due to the knowledge they 
are being evaluated. The main concern with this limitation is the possibility of an 
increased false negative result due to participation awareness (McCambridge, Witton, & 
Elbourne, 2014). 
Observer bias is also a limitation to any clinical research study. The expectation 
of seeing a certain result, or improvement, in participants can lead research observers to 
determine results to be more favorable. Comparable studies have tried to limit observer 
bias by starting all participants on the same day, rather than multiple days, and 
assessments were conducted by the same observer (Krasse et al. 2005). Due to the 
challenges of obtaining research subjects, the PI of this study found it necessary to start 
participants on multiple days, and to use two research assistants, as well as herself, to 
collect data. Although effort was made to provide calibration among research observers, 
the PI acknowledged the need for additional calibration for future research studies. 
Participant compliance to study protocol is another limitation, increasing the 
possibility of outliers and inconsistent results. Participants in this study were asked to 
brush once a day with their study drops, but refrigeration of the drops was necessary to 
preserve the live, active cultures in the probiotic drops. Remembering to retrieve the 
drops from the refrigerator before brushing was a concern during the study design. In 
order to help decrease this limitation, the PI gave each participant a laminated study 
reminder card highlighting the important details of the study. Additional concerns noted 
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by the participants regarding compliance were forgetting to use the drops because of 
travel for work or pleasure, the drops were not part of their regular oral health regimen, 
and difficulty getting the drops out of the bottle due to the slow dropper and cold liquid. 
Also, the amount or dosage used for each application may not have been equal because of 
the difficulty of getting the drops to come out of the vial. Participants were advised 5 
drops per application was the recommended study dose. A few participants ran out of 
study drops before the end of the study, and had to contact the PI to obtain more, and 
some participants returned to final data collection with left over drops in excess of what 
was expected if 5 drops were used each day for the 3-week study period. 
One final limitation of this study is the frequency of probiotic application per day 
in comparison to similar studies. This study had participants use the probiotic and 
placebo mediums once per day. All other comparative research had subjects using the 
probiotic and placebo two or more times per day (Krasse et al., 2005; Nadkemy et al., 
2015; Noordin et al., 2007; Sinkiewicz et al., 2013; Tekce et al., 2015; Toiviainen et al., 
2015; Vivekananda et al., 2010). The lack of statistically significant results in regard to 
the probiotic medium in this study could be attributed to the frequency of use, and 
therefore the overall amount to treatment received by the participants. Once a day use 
may not have been enough to see any result, as the study results indicates. One of the 
methodology concerns the PI had when designing this study was not wanting to alter the 
participant’s home care routine, causing an inadvertent improvement in PS and GI. 
Therefore, the PI choose the lowest acceptable level of brushing each participant should 
have already been performing as the amount of frequency for the probiotic drop 
application, as each participant was brushing with the study therapy. Participants were 
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allowed to brush additional times per day, if that was already part of their pre-study oral 
hygiene regimen. Consequently, the test and control therapies were only administered 
one time per day. 
Recommendations/Suggestions for Future Research 
 
Recommendations that might improve future research were noted during the 
implementation of this study. Initially, utilizing three test groups rather than two may 
have been advisable to compare brushing with toothpaste alone versus toothpaste plus 
placebo drops, and toothpaste plus probiotic drops. There is no research to know how 
brushing with the drops containing sunflower oil would impact oral tissues. Additionally, 
a crossover study design might have been beneficial, as results from using both the test 
drop and the placebo drop could have been compared on each participant (Iniesta et al., 
2012). Comparisons from a crossover study would potentially have more reliability of 
results then the traditional pre and post treatment comparisons performed in this study 
(Iniesta et al., 2012). The PI initially designed this study to utilize a cross-over method 
with an initial 3-week phase, a 2-week wash out period, and a second 3-week phase  
where participants would use each drop. For pragmatic reasons of time and cost, the PI 
choose to reduce the study to a 3-week clinical trial, and eliminate the wash out and 
secondary cross-over phase of the study. 
Future studies may consider utilizing a larger sample size, and a longer study 
period, where participants could return to the test site daily to brush with the test or 
placebo toothpaste under supervision. This would ensure equity of the amount of 
toothpaste used, and length of time brushing, etc. For this study, the PI requested 
participants not change anything about their current homecare routine, except to use the 
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study toothpaste and add the assigned test or placebo drop prior to brushing. Rationale 
for this design being whatever the study subjects were doing prior to the study resulted in 
their current oral health condition. The PI did not want to alter their regimen, as this 
might cause an improvement in oral health, therefore making it difficult to determine if 
improvements resulted from the study drops or the changes in participant’s oral hygiene. 
Making participation compliance easier in future studies could be achieved by 
compounding a toothpaste with a stabilized form of L. reuteri that does not need to be 
refrigerated or added to anything. This would help to confirm the dosage or amount of 
probiotic being administered was the same for each use, and for all participants. 
Comparable research studies have implemented a prophylaxis prior to the 
beginning of the study (Karuppaiah et al.,2013; Nadkemy et al., 2015). This 
methodology takes advantage of the competitive exclusion principle in regard to 
probiotic mechanism of action. This principle suggests two species competing for the 
same resources cannot steadily co-exist (Teughels et al., 2011). Providing a teeth 
cleaning prior to beginning a topical probiotic research study may improve the 
opportunity for adherence of probiotic bacteria to the teeth and oral tissues, due to the 
elimination of competition for adhesion sites and nutrients (Teughels et al., 2011). 
Another reason for a prophylaxis prior to beginning a topical study would be for the 
removal of calculus. The PI noticed on participants with calculus present, bleeding and 
GI were always higher, and bleeding was present at baseline and final data collection. 
Removing this known local irritant would help to eliminate a variable that cannot be 
predicted or controlled without elimination. Some studies implementing a prophylaxis 
prior to the beginning of the study also incorporated and waiting period of two to three 
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weeks before beginning the study, to allow for the participant’s normal oral conditions to 
return. Baseline data was then collected without the presence of any other local irritants 
besides plaque accumulation (Karuppaiah et al.,2013; Nadkemy et al., 2015). 
Future research should also consider the frequency and amount of probiotic being 
administered. This study utilized a once a day, topical, application of the probiotic L. 
reuteri by adding drops containing the probiotic to a toothbrush. Participants then added 
the study toothpaste, and brushed following their usual oral hygiene regimen. This 
method had pros and cons to its design. Positive aspects of this method were by not 
giving home care instructions, or making any changes to the participant’s oral hygiene, 
improvements to PS and GI due to intervention were minimized. Conversely, not 
standardizing participant’s oral hygiene may have produced a situation where probiotic 
application was not administered long enough, effectively, or in large enough quantities 
to produce a desired result, or any result. Therefore, future research designs should 
consider requesting participants brush more than one time per day, and give oral hygiene 
instruction for the recommended brushing and flossing technique to be used during the 
study. Having participants use the probiotic or placebo therapy two or more times per 
day would help ensure adequate dosage of therapeutic agents (Krasse et al., 2005; 
Nadkemy et al., 2015; Noordin et al., 2007; Sinkiewicz et al., 2013; Tekce et al., 2015; 
Toiviainen et al., 2015; Vivekananda et al., 2010). Standardizing participant’s oral 
hygiene for the study period would help to ensure consistent application time and equal 
amounts of probiotic or placebo agents are administered. Participants should be 
interviewed at the beginning and end of the study about their current homecare regimen, 
and any changes during the study should be noted for evaluation during statistical 
EFFICACY OF BRUSHING WITH PROBIOTICS 63  
 
 
analysis. These suggestions should help to eliminate outliers and unintentional outcomes 
to future research. 
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Conclusions 
 
Although results of this clinical study were unexpected, further research regarding 
the use of probiotics as a natural, healthy alternative therapy to antibiotics for the 
treatment and management of oral diseases should continue to be evaluated. The only 
statistically significant differences observed in this study were the GI of the placebo 
group as a whole (p = 0.001), and females from the placebo group (p = 0.004). Several 
research studies reviewed in the process of completing this thesis have shown probiotics 
have great possibilities in the oral cavity. Most researchers agree the type, application 
method, and quantity of probiotic needed to be effective at treating and managing oral 
diseases has yet to be determined. This study confirms frequency of administration of 
probiotics, and therefore overall quantity of probiotics administered, is a considerable 
factor in order to achieve a desired effect. Once a day application is not adequate to 
obtain a dosage potent enough to observe a statistically significant response. Future 
research should focus on developing the foundation of knowledge already established, to 
increase understanding and ability to translate this knowledge into clinical practice. 
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Appendix A 
Instruction form for modified gingival index 
 
Modified Gingival Index: (Löe-Silness, 1963) 
(Adapted from Quizlet Inc. 2017). Retrieved from https://quizlet.com/32081334/community-health-dental-indices-scoring-methods-flash-cards/ 
 
• Score assigned to each of the four areas by inserting probe (based on color, 
consistency & bleeding) 
• Scores facial, lingual, mesial, distal (mesial and distal evaluated from buccal side 
of teeth) (Lang et al., 1973) 
 
SCORE CRITERIA 
1 Normal gingiva or slight color change, mild edema, slight texture change; 
no bleeding 
2 Redness, hypertrophy, edema, glazing; slight bleeding 
3 Marked redness, hypertrophy, edema, ulceration; moderate to heavy 
bleeding 
 
Method of evaluation: 
Insert probe into sulcus 1-2 mm, gently press against gingiva to determine firmness 
Move probe circumferentially in horizontal stroke along soft tissue side of pocket 
Scoring: give each tooth assessed a score of 1-3, and divide score of each tooth by 4 
 
 
 
 
 
 
1 2 
3 
 
 
 
 
 
 
 
 
 
 
 
 
1 
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Appendix B 
Modified Löe-Silness gingival index form 
 
Participant/Drop Number: Group Assigned: (circle one) Group A Group B 
 
 
Collection Interval: (circle one) Baseline Week 3 
 
Date: 
 
 
 
Tooth 
# 
2 3 4 5 6 7 8  9 10 11 12 13 14 15 
Distal        Mesial        
Facial        Facial        
Mesial        Distal        
Lingual        Lingual        
Total 
Score / 
4 
               
 
Tooth 
# 
31 30 29 28 27 26 25  24 23 22 21 20 19 18 
Distal        Mesial        
Facial        Facial        
Mesial        Distal        
Lingual        Lingual        
Total 
Score / 
4 
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Appendix C 
O’Leary plaque score form 
 
Participant/Drop Number: Group Assigned: (circle one) Group A Group B 
 
 
Collection Interval: (circle one) Baseline Week 3 
 
Date: 
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Appendix D 
Inclusion and exclusion criteria form 
 
Inclusion Criteria (Appendix H, Appendix I) 
• Healthy Adults between the ages of 18 and 65 
• At least 20 evaluable teeth 
• Willing to complete the full 8-week study and attend screening and data 
collection dates 
• Habit of brushing teeth at least 1 time per day 
• Participant needs to exhibit gingivitis 
• Participants must be able to read and write the English language at an 
eighth grade level or higher 
Exclusion Criteria (Appendix H, Appendix I) 
• Individuals currently using, or with previous use, of antibiotics for 30 days 
prior to the beginning of the study. Anyone requiring antibiotic treatment 
after the beginning, and during the study, will need to be excluded at that 
time. 
• Individuals who regularly use (more than 3 times per week) probiotics, or 
food containing probiotics, for 30 days prior to the beginning of the study. 
(see entire list in Appendix I) 
• Anyone needing to use probiotics for health reasons, or foods containing 
probiotics, on a regular basis (3 or more times per week) during the 3-week 
study 
• Individuals with a systemic disease or chronic illnesses from the list below: 
Robinson, J. (2016). What are Autoimmune Disorders? Retrieved from 
https://www.webmd.com/a-toz-guides/autoimmune-diseases? 
 
∗  Note: Participants with well controlled diabetes, and/or taking diabetes medication, with an 
A1C of 7 or less may participate in the study. Also, individuals with systemic illnesses in 
remission or well controlled with medication, exhibiting no signs or symptoms of the disease, 
may be in the study). 
 
o Patients diagnosed with Type I or Type II Diabetes, with an A1C 
over 7 
o Patients with autoimmune diseases, not in remission or controlled 
by medication, such as: 
a) Rheumatoid Arthritis 
b) Systemic Lupus Erythematosus (Lupus) 
c) Multiple Sclerosis (MS) 
d) Inflammatory Bowel Disease (IBS), Crohn’s Disease, 
Ulcerative Colitis 
e) Guillain-Barre Syndrome 
f) Chronic Inflammatory Demyelinating Polyneuropathy 
g) Psoriasis 
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h) Graves’ Disease 
i) Hashimoto’s Thyroiditis 
j) Myasthenia Gravis 
k) Vasculitis 
o Patients with Liver disease, Hepatitis B or C or elevated liver 
enzymes 
o Patients that are immune compromised, on immunosuppressive 
medications, have AIDS, or HIV 
o Pulmonary Disease such as Chronic Obstructive Pulmonary 
Disease (COPD), Emphysema, or asthma requiring the use of 
inhalers or nebulizers one or more times each day. 
o Patients using the following medications on a daily basis: 
a) Calcium Channel blockers 
b) Blood thinners/anti-coagulants 
c) Asthma inhalers 
d) Dilantin 
e) Prednisone 
f) Anti-inflammatory 
g) Rheumatoid Arthritis 
h) Antibiotics 
i) Probiotics 
j) Cyclosporine 
• Individuals with an allergy or adverse reactions to sunflower oil, Regular 
flavor Colgate toothpaste, fluoride, or the probiotic L. reuteri 
• Individuals needing antibiotic pre-medication or condition requiring antibiotic 
premedication prior to dental treatment 
• Current users of: (see entire list in Appendix I) 
o Smoking tobacco products such as cigarettes, cigars, pipes 
o Nicotine products used orally such as gum or lozenges 
o Electronic cigarettes or vaping devices 
o Hookah 
o Smoking marijuana 
o Marijuana sublingual drops 
• Anyone currently using chlorhexidine oral solutions 
• Women who are pregnancy, lactating, or breastfeeding 
• Individuals cannot have had a dental prophylaxis or nonsurgical periodontal 
therapy for 6 weeks prior to the beginning of the study. 
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Appendix E 
Medical history 
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Appendix F 
Brushing with probiotics research study questionnaire 
 
1. Have you use any antibiotics or probiotic supplements within the last 30 days? 
YES   NO . If YES, please give details below. 
 
Name of antibiotic or type of probiotic? 
Length of time used? 
Date of last use? 
 
 
 
Do you foresee a need to use this product again during the 3-week research study? 
YES   NO . 
 
2. Do you regularly (3 or more times per week) eat food, or drink beverages, which 
contain probiotics or live active bacterial cultures such as yogurt, Kombucha, 
salad dressings made with yogurt or live active cultures, etc. 
YES   NO . If YES, please give details below. 
 
Is usage for a medical purpose or condition? 
Type of food or beverage? 
If probiotic, what type of bacteria does this item contain? 
Amount of food or beverage consumed during use? 
Are you willing /able to discontinue use for 30 days prior to the beginning of the 
study, and during the 3-week study period, as part of this research study? 
YES   NO . 
 
3. Do you have any known allergies or adverse reactions to Colgate Cavity 
Protection regular flavor toothpaste? 
YES   NO . If YES, please give details below. 
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4. Do you have any known allergies or adverse reactions to sunflower oil? 
YES   NO . If YES, please give details below. 
 
 
5. Do you have any known allergies or adverse reaction to the probiotic 
Lactobacillus reuteri? 
YES   NO . If YES, please give details below. 
 
 
6. Do you use any tobacco, nicotine, electronic cigarettes, hookah, or marijuana 
products? 
YES   NO . If YES, please give details below. 
 
 
7. How often do you brush your teeth? 
 
 
 
8. Do you use dental floss, oral irrigators such as a WaterpikTM, or any other 
adjunctive teeth cleaning items? 
YES   NO . If YES, please give details below. 
 
Item used. 
How often? 
 
 
Complete this section after finishing the study 
 
9. Have you changed anything about your homecare routine since starting the study? 
YES   NO . If YES, please give details below. 
 
 
10. Have you used any of the medications, substances, or food items on the exclusion 
list since beginning the study? 
YES   NO . If YES, please give details below. 
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Appendix G 
Research study schedule 
 
(Sample with a Thursday start date) 
FEBRUARY 
 Sun. Mon. Tues. Wed. Thurs. Fri. Sat. 
Begin 
Study 
    1 
Collect 
Baseline 
Data 
Use 
Drops 
and 
Tooth 
paste 
2 
Use 
Drops 
and 
Tooth 
paste 
3 
Use 
Drops 
and 
Tooth 
paste 
Week 
1 
4 
Use 
Drops 
and 
Tooth 
paste 
5 
Use 
Drops 
and 
Tooth 
paste 
6 
Use 
Drops 
and 
Tooth 
paste 
7 
Use 
Drops 
and 
Tooth 
paste 
8 
Use 
Drops 
and 
Tooth 
paste 
9 
Use 
Drops 
and 
Tooth 
paste 
10 
Use 
Drops 
and 
Tooth 
paste 
Week 
2 
11 
Use 
Drops 
and 
Tooth 
paste 
12 
Use 
Drops 
and 
Tooth 
paste 
13 
Use 
Drops 
and 
Tooth 
paste 
14 
Use 
Drops 
and 
Tooth 
paste 
15 
Use 
Drops 
and 
Tooth 
paste 
16 
Use 
Drops 
and 
Tooth 
paste 
17 
Use 
Drops 
and 
Tooth 
paste 
Week 
3 
18 
Use 
Drops 
and 
Tooth 
paste 
19 
Use 
Drops 
and 
Tooth 
paste 
20 
Use 
Drops 
and 
Tooth 
paste 
21 
Use 
Drops 
and 
Tooth 
paste 
22 
Collect 
Data – 
study 
complete 
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Appendix H 
Decision tree 
 
 
Age 18 - 65 
No systemic disease or chronic illness 
No allergies or adverse reactions to study drop or toothpaste 
At least 20 evaluable teeth 
Willing to complete the study and come in for screening and data collection 
dates 
Brushes at least 1 time per day 
Exhibit gingivitis 
Ability to speak and write in the English language at an eighth grade level 
 
 
 
 
 
Does not meet 
criteria 
 
Meets criteria 
 
 
 
 
 
 
Exclude 
 
 
 
 
 
 
Cannot 
discontinue 
use 30 days 
 
 
Currently using 
Chlorhexidine 
rinse 
 
 
 
 
Can 
discontinue 
use 30 days 
 
 
Pregnant or 
Breast 
feeding 
Need for 
antibiotic Pre- 
Med 
 
 
 
 
 
 
 
 
 
 
 
Can 
Uses or has used 
antibiotics or probiotics 
within the last 30 days 
Uses any items from the 
excluded substances and 
medications list 
 
 
 
Cannot 
before 
study 
 
 
 
Exclude 
before study 
 
 
 
 
Include 
 
 
 
 
Exclude 
discontinue 
use 30 days 
before study 
begins 
discontiue 
use 30 days 
before study 
begins 
 
Include Exclude 
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Appendix I 
Excluded substances, medications, and foods 
 
Probiotics of any form: 
Gum, Lozenges, Mouthrinses, Tablets, Capsules 
 
Medications on the list below: 
Calcium Channel blockers such as: Amlodipine, Caduet, Lotrel, Exforge, 
Twynsta, Tribenzor, Prestalia, Azor, Cardizem/Diltiazem, 
Clevidipine/Cleviprex, Felodipine/Cardene, Nisoldipine/Sular, Verapimil/Calan, 
Nimodipine, Nicardipine, Isradipine 
Blood thinners/anti-coagulants such as: Coumadin, Warfin, Plavix, Aspirin 
Diabetes medications such as: Insulin, Metformin, Glucophage, Lantis, etc. 
Asthma inhalers or other oral inhalers such as Advair, ProAir, Flovent, etc. 
Dilantin or other seizure medications 
Prednisone or other steroids 
Anti-inflammatory medications such as Naproxen, Ketoprofen, Ibuprofen, 
Indomethicin, Sulindac, Meclofenamate, Toradol, Feldene, Diclofenac, 
Celebrex, Mobic/Meloxicam 
Rheumatoid Arthritis medications such as Methotrexate, Celebrex, Plaquenil, 
Enbrel, Remicade, Humira, Sulfasalizine, Arava, etc. 
Antibiotics – all 
Probiotics – all 
Cyclosporine or other immunosuppressive drugs 
 
Foods containing probiotics, natural live active cultures, or added live active cultures 
(Probiotics Now, n.d.): 
Yogurt 
Kombucha 
Salad dressings made from yogurt 
Curd 
Buttermilk or products made from buttermilk 
Kefir 
Cultured cottage cheese 
Miso 
Sauerkraut 
Kimchi 
Pickles and olives made with traditional methods 
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Appendix J 
Recruitment flyer 
GOT TEETH? 
 
If you are age 18 or older, you could be a 
participant in an exciting research study testing 
toothbrushing with probiotics! This study will 
take place at Eastern Washington University in 
the Dental Hygiene Department, Spokane 
Campus, as part of a master’s thesis study. 
 
 
Each person who completes the study will receive a $5 Starbucks gift card, and 
will be entered into a drawing for a chance to win a Sonicare Diamond Clean 
electric toothbrush or professional teeth whitening. 
For more information, contact: 
Cheri Barton RDH, BS, MSDH (c) 
Text: (208) 964-5868 
Email: cbarton2015@eagles.ewu.edu 
Text: (208) 964-5868 
cbarton2015@eagles.ewu.edu 
 
 
Text: (208) 964-5868 
cbarton2015@eagles.ewu.edu 
 
 
Text: (208) 964-5868 
cbarton2015@eagles.ewu.edu 
 
 
Text: (208) 964-5868 
cbarton2015@eagles.ewu.edu 
 
 
Text: (208) 964-5868 
cbarton2015@eagles.ewu.edu 
 
 
Text: (208) 964-5868 
cbarton2015@eagles.ewu.edu 
 
 
Text: (208) 964-5868 
cbarton2015@eagles.ewu.edu 
 
 
Text: (208) 964-5868 
cbarton2015@eagles.ewu.edu 
 
 
Text: (208) 964-5868 
cbarton2015@eagles.ewu.edu 
 
 
Text: (208) 964-5868 
cbarton2015@eagles.ewu.edu 
 
 
Text: (208) 964-5868 
cbarton2015@eagles.ewu.edu 
 
 
Text: (208) 964-5868 
cbarton2015@eagles.ewu.edu 
 
 
Text: (208) 964-5868 
cbarton2015@eagles.ewu.edu 
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Appendix K 
Informational meeting and hand-on training lesson plan 
 
TITLE: Efficacy of Brushing with Probiotics Information and Hands-On Training 
Facilitator: Cheri Barton RDH, BS, MSDH (c) 
 
ESTIMATED LENGTH: 45 minutes INSTRUCTIONAL METHOD: 
Facilitated discussion and hands-on practice 
using study forms and data collection 
methods 
EDUCATIONAL GOAL: 
To introduce thesis study to volunteers, demonstrate use of study forms, and practice data 
collection methods. 
 
INSTRUCTIONAL OBJECTIVES: 
• Explain thesis study (Appendix G, M, K) 
• Discuss screening process 
Medical History and Questionnaire (Appendix E, F) 
Inclusion and Exclusion Criteria (Appendix D, H, I, J) 
• Review data collection forms and methods (Appendix A, B, C) 
• Practice use of the O’Leary Plaque Score and Löe-Silness Gingival Index on 
partners – RA’s 
• Practice using the PS and GI forms by recording data for RA partners – CA’s 
 
 
INSTRUCTIONAL MATERIALS: 
• Dental operatory chair, clinician chair 
• Armamentarium including mirror, probe, air water syringe tip, saliva ejector, 
gauze, cotton tip applicators, disclosing solution, Vaseline 
• PPE including gloves, mask, safety glasses/loupes 
• Copies of study forms and appendices 
 
 
LEARNING ACTIVITY: (40 minutes) 
Volunteers of the study will value the implementation process through actively engaging 
in a discussion on screening and data collection protocol. The PI, RA’s and CA’s of the 
study will practice using the study forms and designated PS and GI methods to collect 
data on a partner. 
 
QUESTION AND ANSWER SESSION: (5 minutes) 
Discuss questions regarding the study and implementation. 
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Appendix L 
Study reminder card 
 
 
 
 
STUDY REMINDERS 
• KEEP DROPS REFRIDGERATED WHEN NOT USING 
• SHAKE DROPS WELL BEFORE EACH USE 
• USE DROPS ONLY ONE TIME PER DAY, EVEN IF YOU BRUSH MORE 
OFTEN 
• USE ONLY 5 DROPS – ADD TO TOOTHBRUSH FIRST, THEN ADD 
TOOTHPASTE 
• USE ONLY THE STUDY TOOTHPASTE WHEN BRUSHING 
• DO NOT RINSE, EAT, OR DRINK AFTER BRUSHING FOR 30 MINUTES 
• DO NOT CHANGE YOUR REGULAR ORAL HYGIENE ROUTINE 
• CHECK OFF THE STUDY SCHEDULE EACH DAY THAT YOU USE THE 
DROPS 
• BRING STUDY SCHEDULE TO EACH DATA COLLECTION 
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Appendix M 
Informed consent document 
 
 
Consent Form 
Efficacy of brushing with probiotics for the reduction of gingivitis 
 
Principal Investigator: Responsible Project Investigator: 
Cheri L. Barton RDH, BS, MSDH (c) Lisa Bilich RDH, MSEd, CHSE 
MSDH Student/Part-time Clinical Professor Professor of Dental Hygiene 
Eastern Washington University Eastern Washington University 
310 N. Riverpoint Blvd. Box E 310 N. Riverpoint Blvd. Box E 
Spokane, WA 99202  Spokane, WA 99202 
(208)964-5868 (cell) (509)828-1295 
(509) 828-1300 (Dental Hygiene Dept. office) 
 
Investigator's  Statement 
This study will attempt to determine the effectiveness of brushing with the probiotic Lactobacillus reuteri, 
as an application method by evaluating the results on a common oral disease, gingivitis. 
 
Purpose and Benefits 
The aim of this study is to evaluate the response adding probiotics to toothpaste prior to brushing will   
have on gingivitis. Gingivitis is an inflammation of the gum tissue that surrounds the teeth, and is caused 
by an accumulation of plaque. Plaque is a sticky biofilm made up of the natural fluid found in the mouth 
called saliva, sugars from the foods we eat and drink, and bacteria that are normal to the oral environment. 
Probiotics are healthy bacteria that are found naturally in many foods and beverages, and can also be  
added to a person’s diet as a supplement, similar to vitamins and minerals. This clinical study is being 
conducted as part of a master’s thesis for partial completion of the requirements needed to receive a 
master’s of dental hygiene degree from Eastern Washington University (EWU). 
 
Procedures 
This study will be a 3-week clinical trial using either probiotic drops containing L. reuteri, or a placebo 
drop consisting of sunflower oil, added to a plain fluoride toothpaste. If admitted into the study, you will 
need to come to the EWU dental hygiene clinic two (2) times for data collection, for approximately one 
hour each. The schedule for this will be at the beginning of the study, and after three weeks has passed, at 
the end of the study. Participation is voluntary, and you may drop out of the study at any time, if you 
choose. 
 
In order to qualify for this study, PI requests that you undergo a screening process to assess your eligibility. 
The screening process will take approximately 2 hours. During the screening, you will need to fill out a 
health history which will include demographic information such address, phone number, and health 
information such as current and past illnesses, medications, alcohol use, and drug use. You will also be 
asked to fill out a questionnaire at the beginning and the end of the study regarding your use of probiotics 
and antibiotics. You may choose not to answer any question you find objectionable. Below is a sample 
question asked on the questionnaire: 
 
11. Have you use any antibiotics or probiotic supplements (tablets or pills) within the last 30 days? 
YES   NO_ . If YES, please give details below. 
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The screening process will follow this model: 
Screening process: 
Phase One: A group presentation will be conducted by the PI to introduced and explain the study. 
Questions regarding the study will be answered, and if you are interested in being a study 
participant, you will be given the informed consent document to read and sign. 
Phase Two: After you have signed the informed consent document, you will be asked to fill out a 
medical history and questionnaire. 
Phase Three: If not excluded from the study in phase two, the PI, or one of her research assistants, 
will conduct a clinical screening on you to ensure you qualify for the study. The clinical screening 
will consist of a plaque score, evaluating visible plaque preset on your teeth, and a gingival 
inflammation score, evaluating gum areas that appear inflamed. After acceptance into the study, 
you will be given other forms and information regarding the beginning of the study. 
 
Risk, Stress or Discomfort 
Any supplement has the possibility of producing an unwanted response from the body or an adverse 
reaction. It is also possible to be allergic, or become allergic, to a substance at any time. Risk level for this 
study has been determined to be minimal. 
 
The probiotic drops to be used for this study contain no milk protein or lactose, nuts, peanuts, soy, corn, 
gluten, wheat, eggs, fish, shellfish, artificial ingredients or flavors. The placebo drop will contain only 
sunflower oil, a common oil used for cooking purposes, and also the primary ingredient in the probiotic 
drops being used for this study. 
 
While possible side effects or allergic reactions for this study are rare, they include: 
• Gastrointestinal upset, gas, bloating, diarrhea, nausea 
• Allergic reaction to fluoride or the plain fluoridated study toothpaste 
• Allergic reaction to sunflower oil, L. reuteri, or any component of the study or placebo 
drops 
 
Possible signs and symptoms of an allergic reaction may present as described below: 
• Gastrointestinal upset, gas, bloating, diarrhea, nausea 
• Oral conditions of the gums or oral tissues such as increased swelling, bleeding, 
tenderness, appearance of sores 
• Burning sensation of oral tissues, tongue, or gums 
• Difficulty breathing, feeling of swelling of the throat/airway, wheezing, shortness of 
breath 
• Appearance of rash or hives 
 
In the event you have an adverse reaction or side effect, you should: 
• Stop all study drops and toothpaste immediately if you experience any unusual signs or 
symptoms 
• Call the PI on her cell phone as soon as you notice any unusual symptoms or reactions 
• Call 911 immediately if you experience difficulty breathing, swelling of the 
throat/airway, wheezing, shortness of breath, rash or hives. As soon as possible, inform 
the PI of this study about the reaction, and discontinue use of the drops and study 
toothpaste. 
 
Other Information 
Your identity will remain confidential. Upon admittance into the study, you will be given an identification 
number, and your identifiable information will be removed from all documents. Participation in this study 
is voluntary, and you are free to withdraw from the study at any time. 
 
As an incentive to become a study participant, and upon completing the full study term, you will receive a 
$5 Starbucks gift card. Additionally, when you complete the study, you will be entered into a drawing for 
the chance to win a Sonicare Diamond Clean electric toothbrush, or professional teeth whitening, including 
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custom whitening trays and two syringes of whitening gel. If you withdraw from the study early, and do 
not complete the full study term, you will not be eligible for these incentives. 
 
Alternative procedures to participation in this study which have been shown to improve oral health and 
reduce gingivitis include professional teeth cleaning by a registered dental hygienist, and dental 
examination by a licensed dentist. 
 
 
 
  Signature of Principal Investigator Date   
 
Subject's Statement 
The study described above has been explained to me, and I voluntarily consent to participate in this study. 
I have had an opportunity to ask questions, and my questions have been answered to my satisfaction. I 
understand that by signing this form, I am not waiving my legal rights. I understand that I will receive a 
signed copy of this form. 
 
 
 
   Signature of Subject Date   
 
 
If you have any concerns about your rights as a participant in this research or any complaints you wish to 
make, you may contact Ruth Galm, Human Protections Administrator, at (509) 359-7971 or 
rgalm@ewu.edu. 
EFFICACY OF BRUSHING WITH PROBIOTICS 93  
 
 
 
 
 
 
 
Curriculum Vita 
 
CHERI BARTON RDH, BS 
Clinical Instructor 
Department of Dental Hygiene 
Eastern Washington University 
 
Home Eastern Washington University 
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